Magnus Ingelman-Sundberg
Om mig
Professor i molekylär toxikologi sedan 1996, sedan 2006 vid sektionen för farmakogenetik på Institutionen för fysiologi och farmakologi. Senior professor sedan 2025-01-01.
Tidigare anställningar vid KI omfattar forskarassistent i fysiologisk kemi 1976-1977; lektor i fysiologisk kemi 1977-1987 (formellt anställd 1982); och tf professor i fysiologisk kemi 1987-1995. Nu sektionschef vid Institutionen för fysiologi och farmakologi. Leder en forskargrupp om cirka 7-8 personer. Forskningen är inriktad på genetiska faktorer av betydelse för interindividuella skillnader i läkemedelseffekter och biverkningar samt studier i ett nytt 3D system rörande mekanismer för läkemedelsutlösta biverkningar och enzyminduktion i lever samt mekanismer för uppkomst och behandling av leversjukdomar.
Utbildning
Civilingenjör, KungligaTekniska Högskolan, Stockholm, 1975
Tekn Dr i fysiologisk kemi 1975
Docent i fysiologisk kemi 1977
Med kand Karolinska Institutet 1978.
Akademiska priser och utmärkelser
Mer än 520 originalarbeten, 38, 961 citeringar (WoS), 62, 092 i Google Scholar), och H-faktor = 101 (ISI) eller 134 (Google Scholar).). Ledamot av Nobelförsamlingen vid Karolinska Institutet 2008-2018. Medlem i Editorial Advisory Boards i t.ex. Trends Pharmacol Sci, Pharmacogenetics and Genomics, Pharmacogenomics, Drug Metabolism Reviews, Drug Metabolism and Disposition, Human Genomics. Ordförande i International Advisory Board of Microsomes and Drug Oxidations 2004-20229. Rankad som en av världens mest inflytelserika forskare (http://sciencewatch.com/sites/sw/files/sw-article/media/worlds-most-inf…) som bygger på citeringar från högt rankade tidskrifter. HIghly cited from Clarivate 2014-2017 coh 2021. Forskningsgruppen rankad outstanding i Karolinska Institutets externa utvärdering External Research Assessment (ERA) 2010. ERC Advanced grant (AdG) för 2017-2022.
Huvudhandledare till doktorsexamen för 33 doktorander, postdoc-utbildning för 34 doktorer. Priser inkluderar The Svedberg Pris, (Svenska föreningen för biokemi och molekylärbiologi) 1989; hedersmedlem i American Society for Biochemistry and Molecular Biology 1990; The Gerhard B Zbinden Föreläsning Award, EUROTOX 1996; The ISSX European Scientific Achievement Award 2003; Bengt Danielsson-priset, Swedish Academy of Pharmaceutical Sciences 2008; The John G Warner Pfizer lecture award in Pharmaceutical Sciences, University of Michigan, USA 2011, 2918 BCPT Nordic Prize in Basic and Clinical Pharmacology and Toxicology. The 2022 R.T. Williams Distinguished Scientific Achievement Award
Övrigt:
Linjenämnden för läkarutbildning : Ordf för studieplanekommitten 3 år, ansvarig för den nya KI 90 GUL studieplan för läkarutbildingen, ledamot 5 år. Docenturnämnden 6 år, ordförande i KIRT 6 år, ordförande för kommittén för valfria perioder i MD läroplan 6 år. Vice ordförande rekryteringsutskottet 3 år, ordförande i rekryteringsutskottet 6 år (till mars 2014) och prodekan (vice dekanus) för rekrytering 2 år. Ordförande i beredningsgrupp vid Naturvetenskapliga forskningsrådet 3 år, medlem i beredningsgrupper vid Naturvetenskapliga forskningsrådet i 6 år, Medicinska forskningsrådet i 6 år, och Norska Forskningsrådet i 6 år.Pedagogiska priser: Mäster 1978, medicinska föreningen; KIs pedagogiska pris 2000. Medlem i Nobelförsamlingen Karolinska Institutet 2008-2018.
Forskningsbeskrivning
Nya in vitro-system har utvecklats som kan förutsäga metabolism och levertoxicitet av läkemedel. Nya genetiska faktorer har identifierats som kan utgöra farmakogenomiska biomarkörer för individualisering av läkemedelsbehandling. Rollen av mutationer för individualiserad läkemedelsterapi undersökes. I leverorganoidsystem med bibehållen leverfenotyp studeras mekanismer och behandling av leversjukdomar såsom steatos, fibros, och hepatit.
Current funding as PI
• Hjärnfonden 2023-2026
• ERC PoC 2023-2025
• Vetenskapsrådet 2022-2024
• Novartis 2024-2026
Undervisning
Har undervisat läkarstudenter sedan 1977 i fysiologisk kemi och basal farmakologi.
Artiklar
- Journal article: SCIENTIFIC REPORTS. 2025;15(1):32470Vukovic PG; Jeremic A; Vezmar M; Milosavljevic F; Pavlovic Z; Pesic D; Drakulic Dordevic J; Pejuskovic B; Markovic B; Ingelman-Sundberg M; Miljevic CD; Maric NP; Jukic MM
- Journal article: DRUG METABOLISM AND DISPOSITION. 2025;53(7):100100Solbakk M; Smith RL; Wollmann BM; Braten LS; Johansson I; Ingelman-Sundberg M; Andreassen OA; Molden E
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2025;118(1):218-231Johansson I; Xanthopoulou EM; Zhou Y; Sanchez-Spitman A; van Der Lee M; Wollmann BM; Storset E; Swen JJ; Guchelaar H-J; Molden E; Jukic MM; Ingelman-Sundberg M
- Journal article: HUMAN GENOMICS. 2025;19(1):62Johansson I; Lu Y; Zhou Y; Krebs K; Akcan M; Milani L; Ingelman-Sundberg M
- Article: NATURE COMMUNICATIONS. 2025;16(1):1418Dusek J; Mejdrova I; Dohnalova K; Smutny T; Chalupsky K; Krutakova M; Skoda J; Rashidian A; Pavkova I; Skach K; Hricova J; Chocholouskova M; Smutna L; Kamaraj R; Hroch M; Lenicek M; Micuda S; Pijnenburg D; van Beuningen R; Holcapek M; Vitek L; Ingelman-Sundberg M; Burk O; Kronenberger T; Nencka R; Pavek P
- Journal article: NEUROSCIENCE APPLIED. 2025;4:105487Atanasov A; Milosavljević F; Brusini I; Manojlović M; Sitarica P; Wang C; Damberg P; Ingelman-Sundberg M; Jukić M
- Journal article: NEUROSCIENCE APPLIED. 2025;4:105432Jeremic A; Vukovic P; Vezmar M; Pesic D; Drakulic J; Milosavljevic F; Pejuskovic B; Milinkovic N; Miljevic C; Markovic B; Ingelman-Sundberg M; Maric-Bojovic N; Jukic M
- Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2024;80(10):1531-1541Storset E; Braten LS; Ingelman-Sundberg M; Johansson I; Molden E; Kringen MK
- Article: JAMA NETWORK OPEN. 2024;7(8):e2425593Milosavljevic F; Manojlovic M; Matkovic L; Molden E; Ingelman-Sundberg M; Leucht S; Jukic MM
- Journal article: EUROPEAN PSYCHIATRY. 2024;67:s44-s45Vukovic PG; Jeremic A; Vezmar M; Pesic D; Pejuskovic B; Dordevic JD; Milosavljevic F; Miljevic C; Maric-Bojovic NP; Markovic B; Ingelman-Sundberg M; Jukic MM
- Article: HEPATOLOGY COMMUNICATIONS. 2024;8(3):e0374van Riet S; Julien A; Atanasov A; Nordling A; Ingelman-Sundberg M
- Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2024;90(3):740-747Wollmann BM; Smith RL; Kringen MK; Ingelman-Sundberg M; Molden E; Storset E
- Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2024;17(2):e13743Smith RL; Wollmann BM; Storset E; Lenk HC; O'Connell KS; Kristiansen MK; Ingelman-Sundberg M; Molden E
- Article: SCIENTIFIC REPORTS. 2024;14(1):1396Trampuz SR; van Riet S; Nordling A; Ingelman-Sundberg M
- Journal article: NEUROSCIENCE APPLIED. 2024;3:105166Atanasov A; Milosavljević F; Brusini I; Manojlović M; Sitarica P; Wang C; Damberg P; Ingelman-Sundberg M; Jukić M
- Journal article: NEUROSCIENCE APPLIED. 2024;3:105109Milosavljević F; Manojlović M; Matkovic L; Molden E; Ingelman-Sundberg M; Leucht S; Jukić M
- Journal article: NEUROSCIENCE APPLIED. 2024;3:104374Vuković P; Jeremić A; Vezmar M; Milosavljević F; Pešić D; Miljević ČD; Đorđević JD; Pejušković B; Pavlović Z; Marić-Bojović NP; Ingelman-Sundberg M; Jukić MM
- Journal article: NEUROSCIENCE APPLIED. 2024;3:104543Jeremic A; Vukovic P; Vezmar M; Pesic D; Drakulic J; Milosavljevic F; Pejuskovic B; Milinkovic N; Miljevic C; Markovic B; Ingelman-Sundberg M; Bojovic NM; Jukic M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023;114(3):673-685Kloditz K; Tewolde E; Nordling A; Ingelman-Sundberg M
- Journal article: THE BIOMEDICAL & LIFE SCIENCES COLLECTION. 2023;2023(6):e1006061Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023;113(6):1284-1294Jarvinen E; Hammer HS; Poetz O; Ingelman-Sundberg M; Stage TB
- Article: PHARMACOGENOMICS. 2023;24(5):243-246van Schaik RHN; Manolopoulos VG; Daly AK; Niemi M; Zukic B; Patrinos GP; Primorac D; Swen JJ; Ingelman-Sundberg M; Morris T; Molden E; Mueller D; Pavlovic S; Russmann S; Ansari M; Henricks LM; van den Broek W; Florindi F; Bozina N; Akin D; Christrup L; Llerena A; Sipeky C; Stankovic S
- Article: LANCET. 2023;401(10374):347-356Swen JJ; van der Wouden CH; Manson LEN; Abdullah-Koolmees H; Blagec K; Blagus T; Boehringer S; Cambon-Thomsen A; Cecchin E; Cheung K-C; Deneer VHM; Dupui M; Ingelman-Sundberg M; Jonsson S; Joefield-Roka C; Just KS; Karlsson MO; Konta L; Koopmann R; Kriek M; Lehr T; Mitropoulou C; Rial-Sebbag E; Rollinson V; Roncato R; Samwald M; Schaeffeler E; Skokou M; Schwab M; Steinberger D; Stingl JC; Tremmel R; Turner RM; van Rhenen MH; Fajardo CLD; Dolzan V; Patrinos GP; Pirmohamed M; Sunder-Plassmann G; Toffoli G; Guchelaar H-J
- Article: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2023;49(1):e12867Milosavljevic F; Brusini I; Atanasov A; Manojlovic M; Vucic M; Orescanin-Dusic Z; Brkljacic J; Miljevic C; Nikolic-Kokic A; Blagojevic D; Wang C; Damberg P; Pesic V; Tyndale RF; Ingelman-Sundberg M; Jukic MM
- Article: CELLS. 2023;12(2):302Trampuz SR; van Riet S; Nordling A; Ingelman-Sundberg M
- Journal article: NEUROSCIENCE APPLIED. 2023;2:102609Atanasov A; Milosavljević F; Brusini I; Manojlović M; Sitarica P; Wang C; Damberg P; Ingelman-Sundberg M; Jukić M
- Journal article: NEUROSCIENCE APPLIED. 2023;2:102913Milosavljević F; Molden E; Ingelman-Sundberg M; Jukić M
- Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2023;16(1):62-72Lenk HC; Lovsletten Smith R; O'Connell KS; Jukic MM; Kringen MK; Andreassen OA; Ingelman-Sundberg M; Molden E
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2022;112(5):1000-1003Pridgeon CS; Johansson I; Ingelman-Sundberg M
- Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2022;15(9):2135-2145Braten LS; Ingelman-Sundberg M; Jukic MM; Molden E; Kringen MK
- Article: PHARMACOGENOMICS JOURNAL. 2022;22(4):247-249Haeggstrom S; Ingelman-Sundberg M; Paabo S; Zeberg H
- Article: CELLS. 2022;11(10):1597Pridgeon CS; Bolhuis DP; Milosavljevic F; Manojlovic M; Vegvari A; Gaetani M; Jukic MM; Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2022;111(5):1165-1174Lenk HC; Kloditz K; Johansson I; Smith RL; Jukic M; Molden E; Ingelman-Sundberg M
- Article: CELLS. 2022;11(9):1388Semkova V; Haupt S; Segschneider M; Bell C; Ingelman-Sundberg M; Hajo M; Weykopf B; Muthukottiappan P; Till A; Bruestle O
- Journal article: NEUROSCIENCE APPLIED. 2022;1:100236Milosavljević F; Brusini I; Atanasov A; Manojlović M; Vučić M; Oreščanin-Dušić Z; Brkljačić J; Sitarica P; Miljević Č; Nikolić-Kokić A; Blagojević D; Wang C; Damberg P; Pešić V; Tyndale R; Ingelman-Sundberg M; Jukić M
- Article: ADVANCES IN PHARMACOLOGY. 2022;95:393-416Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2021;110(3):750-758Jukic MM; Smith RL; Molden E; Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2021;110(3):786-793Braten LS; Haslemo T; Jukic MM; Ivanov M; Ingelman-Sundberg M; Molden E; Kringen MK
- Article: SCIENCE TRANSLATIONAL MEDICINE. 2021;13(603):eabf3637van der Lee M; Allard WG; Vossen RHAM; Baak-Pablo RF; Menafra R; Deiman BALM; Deenen MJ; Neven P; Johansson I; Gastaldello S; Ingelman-Sundberg M; Guchelaar H-J; Swen JJ; Anvar SY
- Article: DRUG METABOLISM AND DISPOSITION. 2021;49(7):DMD-AR-2020-000340-508Riede J; Wollmann BM; Molden E; Ingelman-Sundberg M
- Article: SCHIZOPHRENIA RESEARCH. 2021;228:590-596Smith RL; Tveito M; Kylleso L; Jukic MM; Ingelman-Sundberg M; Andreassen OA; Molden E
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2020;108(4):844-855Hendriks DFG; Vorrink SU; Smutny T; Sim SC; Nordling A; Ullah S; Kumondai M; Jones BC; Johansson I; Andersson TB; Lauschke VM; Ingelman-Sundberg M
- Article: ADVANCED SCIENCE. 2020;7(15):2000248Oliva-Vilarnau N; Vorrink SU; Ingelman-Sundberg M; Lauschke VM
- Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;37:64-69Smith RL; Tveito M; Kylleso L; Jukic MM; Ingelman-Sundberg M; Andreassen OA; Molden E
- Article: PHARMACOGENETICS AND GENOMICS. 2020;30(6):131-144van der Wouden CH; Bohringer S; Cecchin E; Cheung K-C; Lucia Davila-Fajardo C; Deneer VHM; Dolzan V; Ingelman-Sundberg M; Jonsson S; Karlsson MO; Kriek M; Mitropoulou C; Patrinos GP; Pirmohamed M; Rial-Sebbag E; Samwald M; Schwab M; Steinberger D; Stingl J; Sunder-Plassmann G; Toffoli G; Turner RM; van Rhenen MH; van Zwet E; Swen JJ; Guchelaar H-J
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2020;107(5):1240-1255Shekhani R; Steinacher L; Swen JJ; Ingelman-Sundberg M
- Article: CELLS. 2020;9(4):E964-964Hurrell T; Kastrinou-Lampou V; Fardellas A; Hendriks DFG; Nordling A; Johansson I; Baze A; Parmentier C; Richert L; Ingelman-Sundberg M
- Article: NEUROPSYCHOPHARMACOLOGY. 2020;45(3):570-576Braten LS; Haslemo T; Jukic MM; Ingelman-Sundberg M; Molden E; Kringen MK
- Article: TOXICOLOGICAL SCIENCES. 2019;171(2):385-395Hendriks DFG; Hurrell T; Riede J; van der Horst M; Tuovinen S; Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2019;106(4):866-873van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar H-J
- Article: PHARMACOGENOMICS. 2019;20(15):1085-1092Lauschke VM; Nordling A; Zhou Y; Fontalva S; Barragan I; Ingelman-Sundberg M
- Article: PHARMACOGENOMICS. 2019;20(15):1063-1069Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Del Re M; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RHN
- Article: SCIENTIFIC REPORTS. 2019;9(1):11585Prill S; Caddeo A; Baselli G; Jamialahmadi O; Dongiovanni P; Rametta R; Kanebratt KP; Pujia A; Pingitore P; Mancina RM; Linden D; Whatling C; Janefeldt A; Kozyra M; Ingelman-Sundberg M; Valenti L; Andersson TB; Romeo S
- Article: EUROPEAN JOURNAL OF CANCER. 2019;114:128-136Salgado R; Solit DB; Rimm DL; Bogaerts J; Canetta R; Lively T; Lyerly K; Span PN; Bateman-House A; Makady A; Bergmann L; Nagai S; Smith C; Robson M; Savage M; Voest E; Sweeney C; Lambin P; Thomas M; Harris L; Lacombe D; Massard C; Lyerly HK; Yee L; Rimm D; Bateman-Houseaj A; Bergmann L; Nagaiam S; Thomasan M; Cree IA; Hopper S; Robson M; Ingelman-Sundberg M; Maignen F; Besse B; Swierzewski R; Kiermaier A; Lacombex D; Livelyad T; Massard C; Salgadobf R; Golfinopoulos V
- Article: LANCET PSYCHIATRY. 2019;6(5):418-426Jukic MM; Smith RL; Haslemo T; Molden E; Ingelman-Sundberg M
- Article: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. 2019;130:65-77Lauschke VM; Ingelman-Sundberg M
- Article: ARCHIVES OF TOXICOLOGY. 2019;93(2):385-399Copple IM; den Hollander W; Callegaro G; Mutter FE; Maggs JL; Schofield AL; Rainbow L; Fang Y; Sutherland JJ; Ellis EC; Ingelman-Sundberg M; Fenwick SW; Goldring CE; van de Water B; Stevens JL; Park BK
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2019;116(1):217-226Cordero-Herrera I; Kozyra M; Zhuge Z; Haworth SM; Moretti C; Peleli M; Caldeira-Dias M; Jahandideh A; Han H; Cruz JDC; Kleschyov AL; Montenegro MF; Ingelman-Sundberg M; Weitzberg E; Lundberg JO; Carlstrom M
- Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2019;85(1):194-201Haslemo T; Eliasson E; Jukic MM; Ingelman-Sundberg M; Molden E
- Article: TOXICOLOGY LETTERS. 2018;295:187-194Parmentier C; Hendriks DFG; Heyd B; Bachellier P; Ingelman-Sundberg M; Richert L
- Article: SCIENTIFIC REPORTS. 2018;8(1):14297Kozyra M; Johansson I; Nordling A; Ullah S; Lauschke VM; Ingelman-Sundberg M
- Article: TISSUE ENGINEERING PART C-METHODS. 2018;24(9):534-545Baze A; Parmentier C; Hendriks DFG; Hurrell T; Heyd B; Bachellier P; Schuster C; Ingelman-Sundberg M; Richert L
- Article: PHARMACOGENOMICS. 2018;19(14):1133-1138Ingelman-Sundberg M; Lauschke VM
- Article: PHARMACOGENOMICS. 2018;19(12):931-936Jukic MM; Lauschke VM; Saito T; Hiratsuka M; Ingelman-Sundberg M
- Article: TOXICOLOGICAL SCIENCES. 2018;163(2):655-665Vorrink SU; Zhou Y; Ingelman-Sundberg M; Lauschke VM
- Article: GENETICS IN MEDICINE. 2018;20(6):622-629Santos M; Niemi M; Hiratsuka M; Kumondai M; Ingelman-Sundberg M; Lauschke VM; Rodriguez-Antona C
- Article: HUMAN GENOMICS. 2018;12(1):26Ingelman-Sundberg M; Mkrtchian S; Zhou Y; Lauschke VM
- Article: AMERICAN JOURNAL OF PSYCHIATRY. 2018;175(5):463-470Jukic MM; Haslemo T; Molden E; Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2018;103(5):745-748Lauschke VM; Ingelman-Sundberg M
- Article: TOXICOLOGICAL SCIENCES. 2018;162(2):655-666Bell CC; Dankers ACA; Lauschke VM; Sison-Young R; Jenkins R; Rowe C; Goldring CE; Park K; Regan SL; Walker T; Schofield C; Baze A; Foster AJ; Williams DP; van de Ven AWM; Jacobs F; van Houdt J; Lahteenmaki T; Snoeys J; Juhila S; Richert L; Ingelman-Sundberg M
- Article: APPLIED IN VITRO TOXICOLOGY. 2018;4(1):1-12Messner S; Fredriksson L; Lauschke VM; Roessger K; Escher C; Bober M; Kelm JM; Ingelman-Sundberg M; Moritz W
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2018;103(3):399-401Gaedigk A; Ingelman-Sundberg M; Miller NA; Leeder JS; Whirl-Carrillo M; Klein TE
- Journal article: PROCEEDINGS FOR ANNUAL MEETING OF THE JAPANESE PHARMACOLOGICAL SOCIETY. 2018;WCP2018(0):po4-9-16Vorrink SU; Zhou Y; Ingelman-Sundberg M; Lauschke VM
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2017;102(4):688-700Zhou Y; Ingelman-Sundberg M; Lauschke VM
- Journal article: MOLECULAR PSYCHIATRY. 2017;22(8):1224Jukic MM; Opel N; Strom J; Carrillo-Roa T; Miksys S; Novalen M; Renblom A; Sim SC; Penas-Lledo EM; Courtet P; Llerena A; Baune BT; de Quervain DJ; Papassotiropoulos A; Tyndale RF; Binder EB; Dannlowski U; Ingelman-Sundberg M
- Article: MOLECULAR PSYCHIATRY. 2017;22(8):1155-1163Jukic MM; Opel N; Stroem J; Carrillo-Roa T; Miksys S; Novalen M; Renblom A; Sim SC; Penas-Lledo EM; Courtet P; Llerena A; Baune BT; de Quervain DJ; Papassotiropoulos A; Tyndale RF; Binder EB; Dannlowski U; Ingelman-Sundberg M
- Journal article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2017;102(1):152van der Wouden CH; Cambon-Thomsen A; Cecchin E; Cheung KC; Davila-Fajardo CL; Deneer VH; Dolzan V; Ingelman-Sundberg M; Jonsson S; Karlsson MO; Kriek M; Mitropoulou C; Patrinos GP; Pirmohamed M; Samwald M; Schaeffeler E; Schwab M; Steinberger D; Stingl J; Sunder-Plassmann G; Toffoli G; Turner RM; van Rhenen MH; Swen JJ; Guchelaar H-J
- Article: FASEB JOURNAL. 2017;31(6):2696-2708Vorrink SU; Ullah S; Schmidt S; Nandania J; Velagapudi V; Beck O; Ingelman-Sundberg M; Lauschke VM
- Article: DRUG METABOLISM AND DISPOSITION. 2017;45(4):419-429Bell CC; Lauschke VM; Vorrink SU; Palmgren H; Duffin R; Andersson TB; Ingelman-Sundberg M
- Article: ACTA PHARMACEUTICA SINICA B. 2017;7(2):241-248Yu A-M; Ingelman-Sundberg M; Cherrington NJ; Aleksunes LM; Zanger UM; Xie W; Jeong H; Morgan EM; Turnbaugh PJ; Klaassen CD; Bhatt AP; Redinbo MR; Hao P; Waxman DJ; Wang L; Zhong X-B
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2017;101(3):341-358van der Wouden CH; Cambon-Thomsen A; Cecchin E; Cheung KC; Davila-Fajardo CL; Deneer VH; Dolzan V; Ingelman-Sundberg M; Jonsson S; Karlsson MO; Kriek M; Mitropoulou C; Patrinos GP; Pirmohamed M; Samwald M; Schaeffeler E; Schwab M; Steinberger D; Stingl J; Sunder-Plassmann G; Toffoli G; Turner RM; Van Rhenen M; Swen JJ; Guchelaar H-J
- Article: ARCHIVES OF TOXICOLOGY. 2017;91(3):1385-1400Sison-Young RL; Lauschke VM; Johann E; Alexandre E; Antherieu S; Aerts H; Gerets HHJ; Labbe G; Hoet D; Dorau M; Schofield CA; Lovatt CA; Holder JC; Stahl SH; Richert L; Kitteringham NR; Jones RP; Elmasry M; Weaver RJ; Hewitt PG; Ingelman-Sundberg M; Goldring CE; Park BK
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2017;482(3):399-407Lauschke VM; Mkrtchian S; Ingelman-Sundberg M
- Article: GENETICS IN MEDICINE. 2017;19(1):20-29Kozyra M; Ingelman-Sundberg M; Lauschke VM
- Article: HEPATOLOGY. 2016;64(5):1743-1756Lauschke VM; Vorrink SU; Moro SML; Rezayee F; Nordling A; Hendriks DFG; Bell CC; Sison-Young R; Park BK; Goldring CE; Ellis E; Johansson I; Mkrtchian S; Andersson TB; Ingelman-Sundberg M
- Article: SCIENTIFIC REPORTS. 2016;6:35434Hendriks DFG; Puigvert LF; Messner S; Mortiz W; Ingelman-Sundberg M
- Article: PLOS ONE. 2016;11(9):e0162379Nole P; Duijndam B; Stenman A; Juhlin CC; Kozyra M; Larsson C; Ingelman-Sundberg M; Johansson I
- Article: NUCLEIC ACIDS RESEARCH. 2016;44(14):6756-6769Ivanov M; Kals M; Lauschke V; Barragan I; Ewels P; Kaller M; Axelsson T; Lehtio J; Milani L; Ingelman-Sundberg M
- Journal article: CANCER RESEARCH. 2016;76(14_Supplement):3105Presa D; Loadman PM; Nigro G; Sheldrake HM; Sutherland M; Shnyder SD; Le Morvan V; Robert J; Ingelman-Sundberg M; Patterson LH; Pors K
- Article: PHARMACOGENOMICS. 2016;17(8):917-924Lauschke VM; Ingelman-Sundberg M
- Article: SCIENTIFIC REPORTS. 2016;6:25187Bell CC; Hendriks DFG; Moro SML; Ellis E; Walsh J; Renblom A; Puigvert LF; Dankers ACA; Jacobs F; Snoeys J; Sison-Young RL; Jenkins RE; Nordling A; Mkrtchian S; Park BK; Kitteringham NR; Goldring CEP; Lauschke VM; Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2016;99(2):172-185Kalman LV; Agundez JAG; Appell ML; Black JL; Bell GC; Boukouvala S; Bruckner C; Bruford E; Caudle K; Coulthard SA; Daly AK; Del Tredici AL; den Dunnen JT; Drozda K; Everts RE; Flockhart D; Freimuth RR; Gaedigk A; Hachad H; Hartshorne T; Ingelman-Sundberg M; Klein TE; Lauschke VM; Maglott DR; McLeod HL; McMillin GA; Meyer UA; Mueller DJ; Nickerson DA; Oetting WS; Pacanowski M; Pratt VM; Relling MV; Roberts A; Rubinstein WS; Sangkuhl K; Schwab M; Scott SA; Sim SC; Thirumaran RK; Toji LH; Tyndale RF; van Schaik RHN; Whirl-Carrillo M; Yeo KTJ; Zanger UM
- Article: FEBS LETTERS. 2016;590(3):330-339Guo J; Thiess S; Johansson I; Mkrtchian S; Ingelman-Sundberg M
- Article: STEM CELLS INTERNATIONAL. 2016;2016:2475631Pradip A; Steel D; Jacobsson S; Holmgren G; Ingelman-Sundberg M; Sartipy P; Bjorquist P; Johansson I; Edsbagge J
- Article: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 2016;856:259-297Stacey GN; Coecke S; Price A-B; Healy L; Jennings P; Wilmes A; Pinset C; Ingelman-Sundberg M; Louisse J; Haupt S; Kidd D; Robitski A; Jahnke H-G; Lemaitre G; Myatt G
- Article: PHARMACOGENETICS AND GENOMICS. 2015;25(12):584-594Fujikura K; Ingelman-Sundberg M; Lauschke VM
- Article: STEM CELLS. 2015;33(10):2936-2948Peric D; Barragan I; Giraud-Triboult K; Egesipe A-L; Meyniel-Schicklin L; Cousin C; Lotteau V; Petit V; Touhami J; Battini J-L; Sitbon M; Pinset C; Ingelman-Sundberg M; Laustriat D; Peschanski M
- Article: TOXICOLOGICAL SCIENCES. 2015;147(2):412-424Sison-Young RLC; Mitsa D; Jenkins RE; Mottram D; Alexandre E; Richert L; Aerts H; Weaver RJ; Jones RP; Johann E; Hewitt PG; Ingelman-Sundberg M; Goldring CEP; Kitteringham NR; Park BK
- Article: PLOS ONE. 2015;10(9):e0138487Neve EPA; Koefeler H; Hendriks DFG; Nordling A; Gogvadze V; Mkrtchian S; Naslund E; Ingelman-Sundberg M
- Journal article: APPLIED IN VITRO TOXICOLOGY. 2015;1(3):175-186Goldring C; Norris A; Kitteringham N; Aleo MD; Antoine DJ; Heslop J; Howell BA; Ingelman-Sundberg M; Kia R; Kamalian L; Koerber S; Martinou J-C; Mercer A; Moggs J; Naisbitt DJ; Powell C; Sidaway J; Sison-Young R; Snoeys J; van de Water B; Watkins PB; Weaver RJ; Wolf A; Zhang F; Park BK
- Article: PHARMACOGENOMICS JOURNAL. 2015;15(3):288-292Apellaniz-Ruiz M; Inglada-Perez L; Naranjo MEG; Sanchez L; Mancikova V; Curras-Freixes M; de Cubas AA; Comino-Mendez I; Triki S; Rebai A; Rasool M; Moya G; Grazina M; Opocher G; Cascon A; Taboada-Echalar P; Ingelman-Sundberg M; Carracedo A; Robledo M; Llerena A; Rodriguez-Antona C
- Article: PHARMACOGENOMICS JOURNAL. 2015;15(3):201-210Ehmann F; Caneva L; Prasad K; Paulmichl M; Maliepaard M; Llerena A; Ingelman-Sundberg M; Papaluca-Amati M
- Article: PLOS ONE. 2015;10(4):e0122820Choong E; Guo J; Persson A; Virding S; Johansson I; Mkrtchian S; Ingelman-Sundberg M
- Journal article: TRENDS IN PHARMACOLOGICAL SCIENCES. 2015;36(2):65-67Ingeiman-Sundberg M
- Article: CLINICAL CANCER RESEARCH. 2015;21(2):322-328Apellaniz-Ruiz M; Lee M-Y; Sanchez-Barroso L; Gutierrez-Gutierrez G; Calvo I; Garcia-Estevez L; Sereno M; Garcia-Donas J; Castelo B; Guerra E; Leandro-Garcia LJ; Cascon A; Johansson I; Robledo M; Ingelman-Sundberg M; Rodriguez-Antona C
- Article: PHARMACOGENOMICS. 2015;16(9):929-937Lee M-Y; Apellaniz-Ruiz M; Johansson I; Vikingsson S; Bergmann TK; Brosen K; Green H; Rodriguez-Antona C; Ingelman-Sundberg M
- Article: FREE RADICAL BIOLOGY AND MEDICINE. 2015;78:202-212Olayanju A; Copple IM; Bryan HK; Edge GT; Sison RL; Wong MW; Lai Z-Q; Lin Z-X; Dunn K; Sanderson CM; Alghanem AF; Cross MJ; Ellis EC; Ingelman-Sundberg M; Malik HZ; Kitteringham NR; Goldring CE; Park BK
- Article: BMC GENOMICS. 2014;15(1):860Bonder MJ; Kasela S; Kals M; Tamm R; Lokk K; Barragan I; Buurman WA; Deelen P; Greve J-W; Ivanov M; Rensen SS; van Vliet-Ostaptchouk JV; Wolfs MG; Fu J; Hofker MH; Wijmenga C; Zhernakova A; Ingelman-Sundberg M; Franke L; Milani L
- Article: DRUG METABOLISM AND DISPOSITION. 2014;42(9):1401-1406Holmgren G; Sjogren A-K; Barragan I; Sabirsh A; Sartipy P; Synnergren J; Bjorquist P; Ingelman-Sundberg M; Andersson TB; Edsbagge J
- Article: PHARMACOGENOMICS JOURNAL. 2014;14(4):343-349Lee M-Y; Borgiani P; Johansson I; Oteri F; Mkrtchian S; Falconi M; Ingelman-Sundberg M
- Article: ACTA ONCOLOGICA. 2014;53(7):885-891Stenstedt K; Hallstrom M; Ledel F; Ragnhammar P; Ingelman-Sundberg M; Johansson I; Edler D
- Article: OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY. 2014;18(7):446-453Aklillu E; Djordjevic N; Carrillo JA; Makonnen E; Bertilsson L; Ingelman-Sundberg M
- Article: MOLECULAR PSYCHIATRY. 2014;19(6):733-741Persson A; Sim SC; Virding S; Onishchenko N; Schulte G; Ingelman-Sundberg M
- Article: PHARMACOGENOMICS. 2013;14(13):1615-1622Stenstedt K; Travica S; Guo J; Barragan I; Pors K; Patterson L; Edler D; Mkrtchian S; Johansson I; Ingelman-Sundberg M
- Article: DRUG METABOLISM AND DISPOSITION. 2013;41(10):1725-1731Ingelman-Sundberg M; Zhong X-B; Hankinson O; Beedanagari S; Yu A-M; Peng L; Osawa Y
- Article: GENOME BIOLOGY. 2013;14(8):R83Ivanov M; Kals M; Kacevska M; Barragan I; Kasuga K; Rane A; Metspalu A; Milani L; Ingelman-Sundberg M
- Article: JOURNAL OF MEDICINAL CHEMISTRY. 2013;56(15):6273-6277Sheldrake HM; Travica S; Johansson I; Loadman PM; Sutherland M; Elsalem L; Illingworth N; Cresswell AJ; Reuillon T; Shnyder SD; Mkrtchian S; Searcey M; Ingelman-Sundberg M; Patterson LH; Porst K
- Article: MOLECULAR PHARMACEUTICS. 2013;10(8):3152-3163Neve EPA; Artursson P; Ingelman-Sundberg M; Karlgren M
- Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2013;113(2):126-131Choong E; Loryan I; Lindqvist M; Nordling A; el Bouazzaoui S; van Schaik RH; Johansson I; Jakobsson J; Ingelman-Sundberg M
- Article: CLINICAL CANCER RESEARCH. 2013;19(11):2952-2961Travica S; Pors K; Loadman PM; Shnyder SD; Johansson I; Alandas MN; Sheldrake HM; Mkrtchian S; Patterson LH; Ingelman-Sundberg M
- Article: TOXICOLOGICAL SCIENCES. 2013;133(1):67-78Gunness P; Mueller D; Shevchenko V; Heinzle E; Ingelman-Sundberg M; Noor F
- Journal article: DRUG METABOLISM AND DISPOSITION. 2013;41(4):932Dragovic S; Gunness P; Ingelman-Sundberg M; Vermeulen NPE; Commandeur JNM
- Article: NUCLEIC ACIDS RESEARCH. 2013;41(6):e72Ivanov M; Kals M; Kacevska M; Metspalu A; Ingelman-Sundberg M; Milani L
- Article: JOURNAL OF AFFECTIVE DISORDERS. 2013;146(1):91-99Peyrot WJ; Middeldorp CM; Jansen R; Smit JH; de Geus EJC; Hottenga J-J; Willemsen G; Vink JM; Virding S; Barragan I; Ingelman-Sundberg M; Sim SC; Boomsma DI; Penninx BWJH
- Article: DRUG METABOLISM AND DISPOSITION. 2013;41(3):651-658Dragovic S; Gunness P; Ingelman-Sundberg M; Vermeulen NPE; Commandeur JNM
- Article: MOLECULAR PHARMACOLOGY. 2013;83(3):659-670Sivertsson L; Edebert I; Palmertz MP; Ingelman-Sundberg M; Neve EPA
- Article: STEM CELLS AND DEVELOPMENT. 2013;22(4):581-594Sivertsson L; Synnergren J; Jensen J; Bjorquist P; Ingelman-Sundberg M
- Article: METHODS IN MOLECULAR BIOLOGY. 2013;987:251-259Sim SC; Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2012;92(6):727-736Ivanov M; Kacevska M; Ingelman-Sundberg M
- Article: BIOCHIMIE. 2012;94(11):2338-2344Kacevska M; Ivanov M; Wyss A; Kasela S; Milani L; Rane A; Ingelman-Sundberg M
- Article: ANTICANCER RESEARCH. 2012;32(9):3869-3874Stenstedt K; Hallstrom M; Johansson I; Ingelman-Sundberg M; Ragnhammar P; Edler D
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2012;92(2):221-227Haslemo T; Loryan I; Ueda N; Mannheimer B; Bertilsson L; Ingelman-Sundberg M; Molden E; Eliasson E
- Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2012;68(4):407-413Lawson EB; Wu JC; Baldwin RM; Ingelman-Sundberg M; Rosenborg S; Yim D-S; Yin OQP; Capparelli EV; Ma JD
- Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2012;68(4):397-406Loryan I; Lindqvist M; Johansson I; Hiratsuka M; van der Heiden I; van Schaik RHN; Jakobsson J; Ingelman-Sundberg M
- Article: JOURNAL OF PSYCHOPHARMACOLOGY. 2012;26(3):398-407Huezo-Diaz P; Perroud N; Spencer EP; Smith R; Sim S; Virding S; Uher R; Gunasinghe C; Gray J; Campbell D; Hauser J; Maier W; Marusic A; Rietschel M; Perez J; Giovannini C; Mors O; Mendlewicz J; McGuffin P; Farmer AE; Ingelman-Sundberg M; Craig IW; Aitchison KJ
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2012;287(9):6307-6317Neve EPA; Nordling A; Andersson TB; Hellman U; Diczfalusy U; Johansson I; Ingelman-Sundberg M
- Article: TOXICOLOGICAL SCIENCES. 2011;124(2):278-290Yildirimman R; Brolen G; Vilardell M; Eriksson G; Synnergren J; Gmuender H; Kamburov A; Ingelman-Sundberg M; Castell J; Lahoz A; Kleinjans J; van Delft J; Bjorquist P; Herwig R
- Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2011;338(1):302-309Mwinyi J; Cavaco I; Yurdakok B; Mkrtchian S; Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2011;89(6):902-907Kacevska M; Ivanov M; Ingelman-Sundberg M
- Article: ATLA-ALTERNATIVES TO LABORATORY ANIMALS. 2011;39(2):147-171Mandenius C-F; Andersson TB; Alves PM; Batzl-Hartmann C; Bjorquist P; Carrondo MJT; Chesne C; Coecke S; Edsbagge J; Fredriksson JM; Gerlach JC; Heinzle E; Ingelman-Sundberg M; Johansson I; Kuppers-Munther B; Mueller-Vieira U; Noor F; Zeilinger K
- Article: TOXICOLOGICAL SCIENCES. 2011;120(1):1-13Johansson I; Ingelman-Sundberg M
- Article: MOLECULAR PHARMACOLOGY. 2010;78(6):1004-1011Gomez A; Nekvindova J; Travica S; Lee M-Y; Johansson I; Edler D; Mkrtchian S; Ingelman-Sundberg M
- Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2010;66(12):1199-1205Pedersen RS; Brasch-Andersen C; Sim SC; Bergmann TK; Halling J; Petersen MS; Weihe P; Edvardsen H; Kristensen VN; Brosen K; Ingelman-Sundberg M
- Article: BIOCHEMICAL PHARMACOLOGY. 2010;80(10):1592-1600Wang J; Hu Y; Nekvindova J; Ingelman-Sundberg M; Neve EPA
- Article: MOLECULAR PHARMACOLOGY. 2010;78(5):886-894Mwinyi J; Cavaco I; Pedersen RS; Persson A; Burkhardt S; Mkrtchian S; Ingelman-Sundberg M
- Article: JOURNAL OF HEPATOLOGY. 2010;53(3):431-438Sutti S; Vidali M; Mombello C; Sartori M; Ingelman-Sundberg M; Albano E
- Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2010;66(9):871-877Ramsjo M; Aklillu E; Bohman L; Ingelman-Sundberg M; Roh H-K; Bertilsson L
- Article: AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS. 2010;153B(6):1160-1166Sim SC; Nordin L; Andersson TM-L; Virding S; Olsson M; Pedersen NL
- Article: HUMAN GENOMICS. 2010;4(6):402-405Ingelman-Sundberg M; Sim SC
- Article: DRUG METABOLISM AND DISPOSITION. 2010;38(6):995-1002Sivertsson L; Ek M; Darnell M; Edebert I; Ingelman-Sundberg M; Neve EPA
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2010;396(1):90-94Ingelman-Sundberg M; Sim SC
- Article: LIFE SCIENCES. 2010;86(19-20):699-706Mwinyi J; Hofmann Y; Pedersen RS; Nekvindova J; Cavaco I; Mkrtchian S; Ingelman-Sundberg M
- Article: PHARMACOGENOMICS. 2010;11(5):625-627Ingelman-Sundberg M; Gomez A
- Article: HUMAN GENOMICS. 2010;4(4):278-281Sim SC; Ingelman-Sundberg M
- Article: DRUG METABOLISM AND DISPOSITION. 2010;38(3):415-421Mwinyi J; Nekvindova J; Cavaco I; Hofmann Y; Pedersen RS; Landman E; Mkrtchian S; Ingelman-Sundberg M
- Article: JOURNAL OF BIOTECHNOLOGY. 2010;145(3):284-294Brolen G; Sivertsson L; Bjorquist P; Eriksson G; Ek M; Semb H; Johansson I; Andersson TB; Ingelman-Sundberg M; Heins N
- Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2010;51(1):249-254Pasutto F; Chavarria-Soley G; Mardin CY; Michels-Rautenstrauss K; Ingelman-Sundberg M; Fernandez-Martinez L; Weber BHF; Rautenstrauss B; Reis A
- Article: TOXICOLOGY IN VITRO. 2009;23(7):1387-1395Edling Y; Sivertsson LK; Butura A; Ingelman-Sundberg M; Ek M
- Article: DRUG METABOLISM AND DISPOSITION. 2009;37(7):1528-1538Dutheil F; Dauchy S; Diry M; Sazdovitch V; Cloarec O; Mellottee L; Bieche I; Ingelman-Sundberg M; Flinois J-P; de Waziers I; Beaune P; Decleves X; Duyckaerts C; Loriot M-A
- Article: DRUG METABOLISM AND DISPOSITION. 2009;37(7):1505-1512Lofgren S; Baldwin RM; Carleros M; Terelius Y; Fransson-Steen R; Mwinyi J; Waxman DJ; Ingelman-Sundberg M
- Article: PHARMACOGENOMICS JOURNAL. 2009;9(3):208-217Ghotbi R; Gomez A; Milani L; Tybring G; Syvanen A-C; Bertilsson L; Ingelman-Sundberg M; Aklillu E
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2009;85(4):426-430Gomez A; Ingelman-Sundberg M
- Journal article: CHEMMEDCHEM. 2009;4(3):473-474Ingelman‐Sundberg M
- Article: JOURNAL OF HEPATOLOGY. 2009;50(3):572-583Butura A; Nilsson K; Morgan K; Morgan TR; French SW; Johansson I; Schuppe-Koistinen I; Ingelman-Sundberg M
- Article: EUROPEAN JOURNAL OF CANCER. 2009;45(4):705-712Edler D; Stenstedt K; Ohrling K; Hallstrom M; Karlgren M; Ingelman-Sundberg M; Raynhammar P
- Article: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2009;2(1):55-65Gomez A; Ingelman-Sundberg M
- Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2008;64(12):1175-1179Rosenborg SO; Mwinyi J; Andersson M; Baldwin RM; Pedersen RS; Sim SC; Bertilsson L; Ingelman-Sundberg M; Eliasson E
- Article: HUMAN MUTATION. 2008;29(9):1147-1153Chavarria-Soley G; Sticht H; Aklillu E; Ingelman-Sundberg M; Pasutto F; Reis A; Rautenstrauss B
- Article: TOXICOLOGY IN VITRO. 2008;22(6):1588-1594Edling Y; Sivertsson L; Andersson TB; Porsmyr-Palmertz M; Ingelman-Sundberg M
- Article: PHARMACOGENOMICS JOURNAL. 2008;8(4):268-277Rodriguez-Antona C; Niemi M; Backman JT; Kajosaari LI; Neuvonen PJ; Robledo M; Ingelman-Sundberg M
- Article: DRUG METABOLISM AND DISPOSITION. 2008;36(5):955-962Lofgren S; Baldwin RM; Hiratsuka M; Lindqvist A; Carlberg A; Sim SC; Schulke M; Snait M; Edenro A; Fransson-Steen R; Terelius Y; Ingelman-Sundberg M
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2008;17(5):1120-1126Lee K-M; Kang D; Clapper ML; Ingelman-Sundberg M; Ono-Kihara M; Kiyohara C; Min S; Lan Q; Le Marchand L; Lin P; Lung ML; Pinarbasi H; Pisani P; Srivatanakul P; Seow A; Sugimura H; Tokudome S; Yokota J; Taioli E
- Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2008;65(5):767-774Baldwin RM; Ohlsson S; Pedersen RS; Mwinyi J; Ingelman-Sundberg M; Eliasson E; Bertilsson L
- Article: EXPERIMENTAL BIOLOGY AND MEDICINE. 2008;233(3):344-355Ronis MJJ; Butura A; Korourian S; Shankar K; Simpson P; Badeaux J; Albano E; Ingelman-Sundberg M; Badger TM
- Journal article: DRUG DISCOVERY TODAY: TECHNOLOGIES. 2008;5(4):e143-e147
- Article: CYTOGENETIC AND GENOME RESEARCH. 2008;123(1-4):195-204Johansson I; Ingelman-Sundberg M
- Journal article: THE BIOMEDICAL & LIFE SCIENCES COLLECTION. 2007;2007(10):e1001124Ingelman-Sundberg M
- Article: PHARMACOGENOMICS. 2007;8(10):1315-1325Gomez A; Karlgren M; Edler D; Bernal ML; Mkrtchian S; Ingelman-Sundberg M
- Article: REGULATORY PEPTIDES. 2007;142(3):95-100Arakelyan KP; Sahakyan YA; Hayrapetyan LR; Khudaverdyan DN; Ingelman-Sundberg M; Mkrtchian S; Ter-Markosyan A
- Article: BIOCHEMICAL PHARMACOLOGY. 2007;74(3):496-503Ek M; Soderdahl T; Kuppers-Munther B; Edsbagge J; Andersson TB; Bjorquist P; Cotgreave I; Jernstrom B; Ingelman-Sundberg M; Johansson I
- Article: DRUG METABOLISM AND DISPOSITION. 2007;35(6):831-834Herman D; Dolzan V; Ingelman-Sundberg M
- Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2007;63(6):537-546Ghotbi R; Christensen M; Roh H-K; Ingelman-Sundberg M; Aklillu E; Bertilsson L
- Article: GLIA. 2007;55(3):328-340Edling Y; Ingelman-Sundberg M; Simi A
- Journal article: JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS. 2006;29(s1):2INGELMAN‐SUNDBERG M
- Journal article: JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS. 2006;29:1-346Garattini S; Ingelman-Sundberg M; Di Marzo V; Higgins AJ; Van Miert ASJPAM
- Article: PHARMACOGENETICS AND GENOMICS. 2006;16(5):359-367Jiang Z; Dragin N; Jorge-Nebert LF; Martin MV; Guengerich FP; Aklillu E; Ingelman-Sundberg M; Hammons GJ; Lyn-Cook BD; Kadlubar FF; Saldana SN; Sorter M; Vinks AA; Nassr N; von Richter O; Jin L; Nebert DW
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2006;79(4):339-349Westlind-Johnsson A; Hermann R; Huennemeyer A; Hauns B; Lahu G; Nassr N; Zech K; Ingelman-Sundberg M; von Richter O
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006;341(2):451-458Karlgren M; Gomez A; Stark K; Svärd J; Rodriguez-Antona C; Oliw E; Bernal ML; Cajal SRY; Johansson I; Ingelman-Sundberg M
- Article: PHARMACOGENETICS AND GENOMICS. 2006;16(3):191-198Wang J; Sonnerborg A; Rane A; Josephson F; Lundgren S; Stahle L; Ingelman-Sundberg M
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006;340(2):491-497Wang J; Pitarque M; Ingelman-Sundberg M
- Article: METHODS IN MOLECULAR BIOLOGY. 2006;320:183-191Sim SC; Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2006;79(1):103-113Sim SC; Risinger C; Dahl ML; Aklillu E; Christensen M; Bertilsson L; Ingelman-Sundberg M
- Article: METHODS IN MOLECULAR BIOLOGY. 2006;320:183-191Sim SC; Ingelman-Sundberg M
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2005;338(2):1065-1074Keizers PHJ; Schraven LHM; de Graaf C; Hidestrand M; Ingelman-Sundberg M; van Dijk BR; Vermeulen NPE; Commandeur JNM
- Article: BIOCHEMICAL PHARMACOLOGY. 2005;70(8):1253-1261Lussenburg BMA; Keizers PHJ; de Graaf C; Hidestrand M; Ingelman-Sundberg M; Vermeulen NPE; Commandeur JNM
- Article: PHARMACOGENETICS AND GENOMICS. 2005;15(9):625-631Sim SC; Edwards RJ; Boobis AR; Ingelman-Sundberg M
- Article: ATHEROSCLEROSIS. 2005;182(1):37-45Abrahamsson A; Krapivner S; Gustafsson U; Muhrbeck O; Eggertsen G; Johansson I; Persson I; Angelin B; Ingelman-Sundberg M; Björkhem I; Einarsson C; van't Hooft FM
- Article: FREE RADICAL BIOLOGY AND MEDICINE. 2005;39(5):619-630Ronis MJJ; Butura A; Sampey BP; Shankar K; Prior RL; Korourian S; Albano E; Ingelman-Sundberg M; Petersen DR; Badger TM
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2005;280(31):28324-28331Rodriguez-Antona C; Axelson M; Otter C; Rane A; Ingelman-Sundberg M
- Article: TOXICOLOGY IN VITRO. 2005;19(5):621-629Bogni A; Monshouwer M; Moscone A; Hidestrand M; Ingelman-Sundberg M; Hartung T; Coecke S
- Article: CANCER RESEARCH. 2005;65(12):5105-5111Aklillu E; Ovrebo S; Botnen IV; Otter C; Ingelman-Sundberg M
- Article: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2005;29(6):1060-1065Zima T; Albano E; Ingelman-Sundberg M; Arteel GE; Thiele GM; Klassen LW; Sun AY
- Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2005;313(2):814-822Pitarque M; Rodríguez-Antona C; Oscarson M; Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2005;77(4):259-270Rodríguez-Antona C; Jande M; Rane A; Ingelman-Sundberg M
- Article: DRUG METABOLISM AND DISPOSITION. 2005;33(4):570-578Andersson S; Hofmann Y; Nordling Å; Li XQ; Nivelius S; Andersson TB; Ingelman-Sundberg M; Johansson I
- Article: JOURNAL OF NEUROCHEMISTRY. 2005;92(4):915-924Simi A; Edling Y; Ingelman-Sundberg M; Tindberg N
- Article: BREAST CANCER RESEARCH. 2005;7(6):R890-R896Einarsdóttir K; Rylander-Rudqvist T; Humphreys K; Ahlberg S; Jonasdottir G; Weiderpass E; Chia KS; Ingelman-Sundberg M; Persson I; Liu JJ; Hall P; Wedrén S
- Article: CELLULAR SIGNALLING. 2005;17(1):39-48Backlund M; Ingelman-Sundberg M
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2004;279(49):50949-50955Vidali M; Hidestrand M; Eliasson E; Mottaran E; Reale E; Rolla R; Occhino G; Albano E; Ingelman-Sundberg M
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2004;13(9):1515-1520Rylander-Rudqvist T; Wedrén S; Jonasdottir G; Ahlberg S; Weiderpass E; Persson I; Ingelman-Sundberg M
- Article: LIFE SCIENCES. 2004;75(4):469-483Ronis MJJ; Korourian S; Yoon S; Ingelman-Sundberg M; Albano E; Lindros KO; Badger TM
- Article: INTERNATIONAL JOURNAL OF CANCER. 2004;110(2):266-270Smits KM; Benhamou S; Garte S; Weijenberg MP; Alamanos Y; Ambrosone C; Autrup H; Autrup JL; Baranova H; Bathum L; Boffetta P; Bouchardy C; Brockmoller J; Butkiewicz D; Cascorbi I; Clapper ML; Coutelle C; Daly AK; Muzi G; Dolzan V; Duzhak TG; Farker K; Golka K; Haugen A; Hein DW; Hildesheim A; Hirvonen A; Hsieh LL; Ingelman-Sundberg M; Kalina I; Kang D; Katoh T; Kihara M; Ono-Kihara M; Kim H; Kiyohara C; Kremers P; Lazarus P; Le Marchand L; Lechner MC; London S; Manni JJ; Maugard CM; Morgan GJ; Morita S; Nazar-Stewart V; Kristensen VN; Oda Y; Parl FF; Peters WHM; Rannug A; Rebbeck T; Pinto LFR; Risch A; Romkes M; Salagovic J; Schoket B; Seidegard J; Shields PG; Sim E; Sinnett D; Strange RC; Stucker I; Sugimura H; To-Figueras J; Vineis P; Yu MC; Zheng W; Pedotti P; Taioli E
- Article: PHARMACOGENETICS AND GENOMICS. 2004;14(6):369-379von Richter O; Pitarque M; Rodríguez-Antona C; Testa A; Mantovani R; Oscarson M; Ingelman-Sundberg M
- Article: BIOCHEMICAL PHARMACOLOGY. 2004;67(7):1389-1397Fang C; Yoon SJ; Tindberg N; Järveläinen HA; Lindros KO; Ingelman-Sundberg M
- Article: BIOCHEMICAL PHARMACOLOGY. 2004;67(7):1249-1258Butura A; Johansson I; Nilsson K; Wärngård L; Ingelman-Sundberg M; Schuppe-Koistinen I
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2004;315(3):679-685Karlgren M; Backlund M; Johansson I; Oscarson M; Ingelman-Sundberg M
- Article: HUMAN MUTATION. 2004;23(3):258-266Pitarque M; von Richter O; Rodríguez-Antona C; Wang J; Oscarson M; Ingelman-Sundberg M
- Article: MOLECULAR PHARMACOLOGY. 2004;65(2):416-425Backlund M; Ingelman-Sundberg M
- Article: BIOCHEMISTRY. 2003;42(49):14566-14575Neve EPA; Hidestrand M; Ingelman-Sundberg M
- Article: DRUG METABOLISM AND DISPOSITION. 2003;31(11):1310-1314Tamási V; Hazai E; Porsmyr-Palmertz M; Ingelman-Sundberg M; Vereczkey L; Monostory K
- Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(7):533-536Aklillu E; Carrillo JA; Makonnen E; Bertilsson L; Ingelman-Sundberg M
- Article: CARCINOGENESIS. 2003;24(9):1533-1539Rylander-Rudqvist T; Wedrén S; Granath F; Humphreys K; Ahlberg S; Weiderpass E; Oscarson M; Ingelman-Sundberg M; Persson I
- Article: MOLECULAR PHARMACOLOGY. 2003;64(3):659-669Aklillu E; Carrillo JA; Makonnen E; Hellman K; Pitarque M; Bertilsson L; Ingelman-Sundberg M
- Article: DRUG METABOLISM AND DISPOSITION. 2003;31(9):1093-1102Salonen JS; Nyman L; Boobis AR; Edwards RJ; Watts P; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Guillouzo A; Corcos L; Goldfarb PS; Lewis DFV; Taavitsainen A; Pelkonen O
- Article: DRUG METABOLISM AND DISPOSITION. 2003;31(6):755-761Westlind-Johnsson A; Malmebo S; Johansson A; Otter C; Andersson TB; Johansson I; Edwards RJ; Boobis AR; Ingelman-Sundberg M
- Article: CANCER CAUSES & CONTROL. 2003;14(4):339-346Le Marchand LC; Guo CF; Benhamou S; Bouchardy C; Cascorbi I; Clapper ML; Garte S; Haugen A; Ingelman-Sundberg M; Kihara M; Rannug A; Ryberg D; Stücker I; Sugimura H; Taioli E
- Article: MOLECULAR PHARMACOLOGY. 2003;63(5):1180-1189Rodríguez-Antona C; Bort R; Jover R; Tindberg N; Ingelman-Sundberg M; Gómez-Lechón MJ; Castell JV
- Article: INTERNATIONAL JOURNAL OF CANCER. 2003;104(5):650-657Vineis P; Veglia F; Benhamou S; Butkiewicz D; Cascorbi I; Clapper ML; Dolzan V; Haugen A; Hirvonen A; Ingelman-Sundberg M; Kihara M; Kiyohara C; Kremers P; Le Marchand L; Ohshima S; Pastorelli R; Rannug A; Romkes M; Schoket B; Shields P; Strange RC; Stucker I; Sugimura H; Garte S; Gaspart L; Taioli E
- Article: CARCINOGENESIS. 2003;24(4):681-687Wedrén S; Rudqvist TR; Granath F; Weiderpass E; Ingelman-Sundberg M; Persson I; Magnusson C
- Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2003;304(3):1048-1054Hakkola J; Hu Y; Ingelman-Sundberg M
- Article: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2003;27(2):336-347Badger TM; Ronis MJJ; Seitz HK; Albano E; Ingelman-Sundberg M; Lieber CS
- Article: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2002;408(1):58-68Zgoda VG; Arison B; Mkrtchian S; Ingelman-Sundberg M; Correia MA
- Article: JOURNAL OF NEUROCHEMISTRY. 2002;83(3):727-737Simi A; Porsmyr-Palmertz M; Hjertén A; Ingelman-Sundberg M; Tindberg N
- Journal article: DRUG NEWS AND PERSPECTIVES. 2002;15(8):528-534Aklillu E; Hidestrand M; Ingelman-Sundberg M; Malmebo S; Westlind A
- Journal article: CARCINOGENESIS. 2002;23(10):1771Benhamou S; Lee WJ; Alexandrie AK; Boffetta P; Bouchardy C; Butkiewicz D; Brockmöller J; Clapper ML; Daly A; Dolzan V; Ford J; Gaspari L; Haugen A; Hirvonen A; Husgafvel-Pursiainen K; Ingelman-Sundberg M; Kalina I; Kihara M; Kremers P; Le Marchand L; London SJ; Nazar-Stewart V; Onon-Kihara M; Rannug A; Romkes M; Ryberg D; Seidegard J; Shields P; Strange RC; Stücker I; To-Figueras J; Brennan P; Taioli E
- Article: HUMAN MUTATION. 2002;20(4):275-283Oscarson M; McLellan RA; Asp V; Ledesma M; Ruiz MLB; Sinues B; Rautio A; Ingelman-Sundberg M
- Article: CARCINOGENESIS. 2002;23(8):1343-1350Benhamou S; Lee WJ; Alexandrie AK; Boffetta P; Bouchardy C; Butkiewicz D; Brockmöller J; Clapper ML; Daly A; Dolzan V; Ford J; Gaspari L; Haugen A; Hirvonen A; Husgafvel-Pursiainen K; Ingelman-Sundberg M; Kalina I; Kihara M; Kremers P; Le Marchand L; London SJ; Nazar-Stewart V; Onon-Kihara M; Rannug A; Romkes M; Ryberg D; Seidegard J; Shields P; Strange RC; Stücker I; To-Figueras J; Brennan P; Taioli E
- Article: PHARMACOGENETICS AND GENOMICS. 2002;12(5):375-383Aklillu E; Herrlin K; Gustafsson LL; Bertilsson L; Ingelman-Sundberg M
- Article: GASTROENTEROLOGY. 2002;123(1):325-335Bardag-Gorce F; French BA; Li J; Riley NE; Yuan QX; Valinluck V; Fu P; Ingelman-Sundberg M; Yoon S; French SW
- Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2002;127(2):293-302Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
- Journal article: MOLECULAR PHARMACOLOGY. 2002;61(3):586-594Aklillu E; Oscarson M; Hidestrand M; Leidvik B; Otter C; Ingelman-Sundberg M
- Article: MOLECULAR PHARMACOLOGY. 2002;61(3):586-594Aklillu E; Oscarson M; Hidestrand M; Leidvik B; Otter C; Ingelman-Sundberg M
- Journal article: DRUG METABOLISM AND PHARMACOKINETICS. 2002;17(6):491-495Oscarson M; Ingelman-Sundberg M
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2002;71(1):77-88Wennerholm A; Dandara C; Sayi J; Svensson JO; Abdi YA; Ingelman-Sundberg M; Bertilsson L; Hasler J; Gustafsson LL
- Article: PHARMACOGENETICS AND GENOMICS. 2001;11(9):815-824Hedberg JJ; Backlund M; Strömberg P; Lönn SS; Dahl ML; Ingelman-Sundberg M; Höög JO
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2001;10(12):1239-1248Garte S; Gaspari L; Alexandrie AK; Ambrosone C; Autrup H; Autrup JL; Baranova H; Bathum L; Benhamou S; Boffetta P; Bouchardy C; Breskvar K; Brockmoller J; Cascorbi I; Clapper ML; Coutelle C; Daly A; Dell'Omo M; Dolzan V; Dresler CM; Fryer A; Haugen A; Hein DW; Hildesheim A; Hirvonen A; Hsieh LL; Ingelman-Sundberg M; Kalina I; Kang DH; Kihara M; Kiyohara C; Kremers P; Lazarus P; Le Marchand L; Lechner MC; van Lieshout EMM; London S; Manni JJ; Maugard CM; Morita S; Nazar-Stewart V; Noda K; Oda Y; Parl FF; Pastorelli R; Persson I; Peters WHM; Rannug A; Rebbeck T; Risch A; Roelandt L; Romkes M; Ryberg D; Salagovic J; Schoket B; Seidegard J; Shields PG; Sim E; Sinnet D; Strange RC; Stücker I; Sugimura H; To-Figueras J; Vineis P; Yu MC; Taioli E
- Article: PHARMACOGENETICS AND GENOMICS. 2001;11(9):745-746Evans WE; Ingelman-Sundberg M
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2001;288(4):1059-1063Hosseinpour F; Hidestrand M; Ingelman-Sundberg M; Wikvall K
- Article: DRUG METABOLISM AND DISPOSITION. 2001;29(11):1480-1484Hidestrand M; Oscarson M; Salonen JS; Nyman L; Pelkonen O; Turpeinen M; Ingelman-Sundberg M
- Article: LAKARTIDNINGEN. 2001;98(42):4554-4555Ahlbom A; Adami HO; Ekbom A; Hagmar L; Ingelman-Sundberg M
- Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2001;52(4):447-450Scordo MG; Aklillu E; Yasar U; Dahl ML; Spina E; Ingelman-Sundberg M
- Article: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2001;482(1-2):11-19Ingelman-Sundberg M
- Journal article: INTERNATIONAL CONGRESS SERIES. 2001;1220:175-186Ingelman-Sundberg M
- Article: PHARMACOGENETICS AND GENOMICS. 2001;11(5):417-427Wennerholm A; Johansson I; Hidestrand M; Bertilsson L; Gustafsson LL; Ingelman-Sundberg M
- Article: DRUG METABOLISM AND DISPOSITION. 2001;29(7):1051-1056Yasar Ü; Tybring G; Hidestrand M; Oscarson M; Ingelman-Sundberg M; Dahl ML; Eliasson E
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2001;284(2):455-460Pitarque M; von Richter O; Oke B; Berkkan H; Oscarson M; Ingelman-Sundberg M
- Article: XENOBIOTICA. 2001;31(6):321-343Pelkonen O; Myllynen P; Taavitsainen P; Boobis AR; Watts P; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Guillouzo A; Corcos L; Goldfarb PS; Lewis DFV
- Article: STRUCTURE. 2001;9(6):457-471Liepinsh E; Baryshev M; Sharipo A; Ingelman-Sundberg M; Otting G; Mkrtchian S
- Article: DRUG METABOLISM AND DISPOSITION. 2001;29(5):712-720Andersson TB; Sjöberg H; Hoffmann KJ; Boobis AR; Watts P; Edwards RJ; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Goldfarb PS; Lewis DFV; Corcos L; Guillouzo A; Taavitsainen P; Pelkonen O
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2001;276(14):11317-11322Neve EPA; Ingelman-Sundberg M
- Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2001;297(1):206-214Werlinder V; Backlund M; Zhukov A; Ingelman-Sundberg M
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2001;281(2):529-535Rylander T; Neve EPA; Ingelman-Sundberg M; Oscarson M
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2000;279(1):23-29The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcoholBardag-Gorce F; Yuan QX; Li J; French BA; Fang C; Ingelman-Sundberg M; French SW
- Journal article: EXPERIMENTAL BIOLOGY AND MEDICINE. 2000;224(4):302-308Inhibition of Ethanol‐Induced Liver Disease in the Intragastric Feeding Rat Model by ChlormethiazoleGouillon Z; Lucas D; Li J; Hagbjork AL; French BA; Fu P; Fang C; Ingelman‐Sundberg M; Donohue TM; French SW
- Article: EXPERIMENTAL BIOLOGY AND MEDICINE. 2000;224(4):302-308Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazoleGouillon ZQ; Lucas D; Li J; Hagbjork AL; French BA; Fu P; Fang C; Ingelman-Sundberg M; Donohue TM; French SW
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2000;274(3):684-688Badger TM; Hoog JO; Svensson S; McGehee RE; Fang C; Ronis MJJ; Ingelman-Sundberg M
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2000;275(29):21844-21849Bylund J; Hidestrand M; Ingelman-Sundberg M; Oliw EH
- Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2000;20(7):1077-1088Simi A; Ingelman-Sundberg M; Tindberg N
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2000;275(22):17130-17135Neve EPA; Ingelman-Sundberg M
- Article: JOURNAL OF HEPATOLOGY. 2000;32(6):900-910Järveläinen HA; Fang C; Ingelman-Sundberg M; Lukkari TA; Sippel H; Lindros KO
- Article: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2000;378(1):175-181McLellan RA; Oscarson M; Hidestrand M; Leidvik B; Jonsson E; Otter C; Ingelman-Sundberg M
- Article: BIOCHEMICAL PHARMACOLOGY. 2000;59(11):1425-1432Longo V; Ingelman-Sundberg M; Amato G; Salvetti A; Gervasi PG
- Article: PHARMACOGENETICS AND GENOMICS. 1999;9(6):707-714Wennerholm A; Johansson I; Massele AY; Jande M; Alm C; Aden-Abdi Y; Dahl ML; Ingelman-Sundberg M; Bertilsson L; Gustafsson LL
- Article: FEBS LETTERS. 1999;460(2):321-327Oscarson M; McLellan RA; Gullstén H; Agúndez JAG; Benítez J; Rautio A; Raunio H; Pelkonen O; Ingelman-Sundberg M
- Journal article: PHARMACOGENETICS AND GENOMICS. 1999;9(5):657Bernal ML; Sinues B; Johansson I; McLellan RA; Wennerholm A; Dahl M-L; Ingelman-Sundberg M; Bertilsson L
- Article: PHARMACOGENETICS AND GENOMICS. 1999;9(5):657-660Bernal ML; Sinues B; Johansson I; McLellan RA; Wennerholm A; Dahl ML; Ingelman-Sundberg M; Bertilsson L
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1999;263(2):286-293Hu Y; Hakkola J; Oscarson M; Ingelman-Sundberg M
- Article: FRONTIERS IN BIOSCIENCE - LANDMARK. 1999;4:a16-a25Gouillon ZQ; Miyamoto K; Donohue TM; Wan YJ; French BA; Nagao Y; Fu P; Reitz RC; Hagbjork A; Yap C; Yuan QX; Ingelman-Sundberg M; French SW
- Journal article: BIOCHEMICAL SOCIETY TRANSACTIONS. 1999;27(3):a61Ingelman-Sundberg M
- Article: BIOCHEMICAL JOURNAL. 1999;340(Pt 2):453-458Zhukov A; Ingelman-Sundberg M
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1999;259(1):201-205Westlind A; Löfberg L; Tindberg N; Andersson TB; Ingelman-Sundberg M
- Article: INTERNATIONAL JOURNAL OF CANCER. 1999;81(3):325-329Persson I; Johansson I; Lou YC; Yue QY; Duan LS; Bertilsson L; Ingelman-Sundberg M
- Article: XENOBIOTICA. 1999;29(5):437-451Chen GF; Ronis MJJ; Ingelman-Sundberg M; Badger TM
- Article: HEPATOLOGY. 1999;29(5):1503-1510Järveläinen HA; Fang C; Ingelman-Sundberg M; Lindros KO
- Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1999;289(2):847-852Simi A; Ingelman-Sundberg M
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1999;258(1):227Yasar Ü; Eliasson E; Dahl ML; Johansson I; Ingelman-Sundberg M; Sjöqvist F
- Article: FEBS LETTERS. 1999;448(1):105-110Oscarson M; McLellan RA; Gullstén H; Yue QY; Lang MA; Bernal ML; Sinues B; Hirvonen A; Raunio H; Pelkonen O; Ingelman-Sundberg M
- Article: ARCHIVES OF TOXICOLOGY. 1999;73(1):33-40Nedelcheva V; Gut I; Soucek P; Tichavská B; Tynkova L; Mráz J; Guengerich FP; Ingelman-Sundberg M
- Article: FEBS JOURNAL. 1999;261(1):66-71Backlund M; Weidolf L; Ingelman-Sundberg M
- Journal article: MOLECULAR PHARMACOLOGY. 1999;55(2):223-233Lytton SD; Helander A; Zhang-Gouillon Z-Q; Stokkeland K; Bordone R; Aricò S; Albano E; French SW; Ingelman-Sundberg M
- Article: MOLECULAR PHARMACOLOGY. 1999;55(2):223-233Lytton SD; Helander A; Zhang-Gouillon ZQ; Stokkeland K; Bordone R; Aricò S; Albano E; French SW; Ingelman-Sundberg M
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1999;254(3):628-631Yasar Ü; Eliasson E; Dahl ML; Johansson I; Ingelman-Sundberg M; Sjoqvist F
- Article: GENE. 1999;226(2):327-338Lundqvist E; Johansson I; Ingelman-Sundberg M
- Article: JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY. 1999;13(3-4):223-226Raucy JL; Ingelman-Sundberg M; Carpenter S; Rannug A; Rane A; Franklin M; Romkes M
- Article: TOXICOLOGICAL SCIENCES. 1999;47(1):110-117Korourian S; Hakkak R; Ronis MJJ; Shelnutt SR; Waldron J; Ingelman-Sundberg M; Badger TM
- Article: FEBS LETTERS. 1998;438(3):201-205Oscarson M; Gullstén H; Rautio A; Bernal ML; Sinues B; Dahl ML; Stengård JH; Pelkonen O; Raunio H; Ingelman-Sundberg M
- Article: FEBS LETTERS. 1998;431(3):322-326Mkrtchiana S; Baryshev M; Matvijenko O; Sharipo A; Sandalova T; Schneider G; Ingelman-Sundberg M
- Article: HEPATOLOGY. 1998;27(5):1304-1310Fang C; Lindros KO; Badger TM; Ronis MJJ; Ingelman-Sundberg M
- Article: PHARMACOGENETICS AND GENOMICS. 1998;8(2):119-123Bathum L; Johansson I; Ingelman-Sundberg M; Horder M; Brosen K
- Article: FEBS JOURNAL. 1998;251(1-2):304-313Mkrtchian S; Fang C; Hellman U; Ingelman-Sundberg M
- Article: BIOCHEMICAL PHARMACOLOGY. 1998;55(2):123-129Ronis MJJ; Huang J; Longo V; Tindberg N; IngelmanSundberg M; Badger TM
- Article: BIOCHEMICAL PHARMACOLOGY. 1997;54(12):1323-1329Martini R; IngelmanSundberg M; Murray M
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1997;272(50):31755-31763Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cellsBacklund M; Johansson I; Mkrtchian S; IngelmanSundberg M
- Article: MOLECULAR PHARMACOLOGY. 1997;52(6):958-965McLellan RA; Oscarson M; Alexandrie AK; Seidegård J; Evans DAP; Rannug A; Ingelman-Sundberg M
- Article: MOLECULAR PHARMACOLOGY. 1997;52(6):1034-1040Oscarson M; Hidestrand M; Johansson I; Ingelman-Sundberg M
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1997;238(2):420-424Parola M; Robino G; Bordone R; Leonarduzzi G; Casini A; Pinzani M; Neve E; Bellomo G; Dianzani MU; IngelmanSundberg M; Albano E
- Article: BIOTECHNIQUES. 1997;23(1):52-58Fang C; Mkrtchian S; IngelmanSundberg M
- Article: FEBS JOURNAL. 1997;247(1):37-43Zhukov A; IngelmanSundberg M
- Article: PHARMACOGENETICS AND GENOMICS. 1997;7(3):187-191McLellan RA; Oscarson M; Seidegard J; Evans DAP; IngelmanSundberg M
- Article: MOLECULAR PHARMACOLOGY. 1997;51(3):370-376Hu Y; Oscarson M; Johansson I; Yue QY; Dahl ML; Tabone M; Arinco S; Albano E; IngelmanSundberg M
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1997;231(1):227-230Persson I; Johansson I; IngelmanSundberg M
- Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1997;1337(1):85-95Zhukov A; Hellman U; IngelmanSundberg M
- Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1997;280(1):506-511Lindros KO; Oinonen T; Johansson I; IngelmanSundberg M
- Article: PHARMACOGENETICS AND GENOMICS. 1996;6(6):521-526Persson I; Aklillu E; Rodrigues F; Bertilsson L; IngelmanSundberg M
- Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 1996;42(6):713-719Masimirembwa C; Persson I; Bertilsson L; Hasler J; IngelmanSundberg M
- Article: ARCHIVES OF TOXICOLOGY. 1996;71(1-2):45-56Gut I; Nedelcheva V; Soucek P; Stopka P; Vodicka P; Gelboin HV; IngelmanSundberg M
- Article: MOLECULAR PHARMACOLOGY. 1996;50(5):1065-1072Tindberg N; Baldwin HA; Cross AJ; IngelmanSundberg M
- Article: JOURNAL OF NEUROCHEMISTRY. 1996;67(5):2066-2073Tindberg N; IngelmanSundberg M
- Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 1996;51(2):117-122Masimirembwa C; Hasler J; Bertilssons L; Johansson I; Ekberg O; IngelmanSundberg M
- Article: PHARMACOGENETICS AND GENOMICS. 1996;6(5):441-447Roh HK; Dahl ML; Johansson I; IngelmanSundberg M; Cha YN; Bertilsson L
- Article: JOURNAL OF HEPATOLOGY. 1996;25(4):538-546Stal P; Johansson I; IngelmanSundberg M; Hagen K; Hultcrantz R
- Article: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 1996;333(2):459-465Neve EPA; Eliasson E; Pronzato MA; Albano E; Marinari U; IngelmanSundberg M
- Article: PHARMACOGENETICS AND GENOMICS. 1996;6(4):351-355Johansson I; Lundqvist E; Dahl ML; IngelmanSundberg M
- Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1996;278(1):441-446Aklillu E; Persson I; Bertilsson L; Johansson I; Rodrigues F; IngelmanSundberg M
- Article: GASTROENTEROLOGY. 1996;111(1):206-216Clot P; Albano E; Eliasson E; Tabone M; Arico S; Israel Y; Moncada C; IngelmanSundberg M
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1996;221(2):318-322IngelmanSundberg M; Hagbjork AL; Ueng YF; Yamazaki H; Guengerich FP
- Article: BIOCHEMICAL PHARMACOLOGY. 1996;51(1):61-69Hakkak R; Korourian S; Ronis MJJ; IngelmanSundberg M; Badger TM
- Article: HEPATOLOGY. 1996;23(1):155-163Albano E; Clot P; Morimoto M; Tomasi A; IngelmanSundberg M; French SW
- Article: JOURNAL OF NUTRITION. 1995;125(12):2953-2964MORIMOTO M; REITZ RC; MORIN RJ; NGUYEN K; INGELMANSUNDBERG M; FRENCH SW
- Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1995;275(1):79-83LINDROS KO; BADGER T; RONIS M; INGELMANSUNDBERG M; KOIVUSALO M
- Article: BIOCHEMICAL PHARMACOLOGY. 1995;50(2):155-161HU Y; INGELMANSUNDBERG M; LINDROS KO
- Article: EUROPEAN JOURNAL OF PHARMACOLOGY. 1995;293(2):123-131SCHMALIX WA; BARRENSCHEEN M; LANDSIEDEL R; JANZOWSKI C; EISENBRAND G; GONZALEZ F; ELIASSON E; INGELMANSUNDBERG M; PERCHERMEIER M; GREIM H; DOEHMER J
- Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1995;274(1):516-520DAHL ML; JOHANSSON I; BERTILSSON L; INGELMANSUNDBERG M; SJOQVIST F
- Article: FEBS JOURNAL. 1995;230(3):914-919BADGER TM; RONIS MJJ; INGELMANSUNDBERG M; HAKKAK R
- Journal article: HEPATOLOGY. 1995;21(6):1610-1617Morimoto M; Hagbjork A-L; Wan Y-JY; Fu PC; Clot P; Albano E; Ingelman-Sundberg M; French SW
- Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 1995;57(6):656-661MASIMIREMBWA C; BERTILSSON L; JOHANSSON I; HASLER JA; INGELMANSUNDBERG M
- Article: HEPATOLOGY. 1995;21(6):1610-1617MORIMOTO M; HAGBJORK AL; WAN YJY; FU PC; CLOT P; ALBANO E; INGELMANSUNDBERG M; FRENCH SW
- Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1995;1243(3):414-420ALBANO E; COMOGLIO A; CLOT P; IANNONE A; TOMASI A; INGELMANSUNDBERG M
- Article: INFLAMMATION. 1995;19(2):143-156MUNTANE J; LONGO V; MITJAVILA MT; GERVASI PG; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1994;48(10):1953-1965RONIS MJJ; INGELMANSUNDBERG M; BADGER TM
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1994;48(9):1823-1833MCGEHEE RE; RONIS MJJ; COWHERD RM; INGELMANSUNDBERG M; BADGER TM
- Journal article: EXPERIMENTAL BIOLOGY AND MEDICINE. 1994;207(2):197-205MORIMOTO M; ZERN MA; HAGBJORK AL; INGELMANSUNDBERG M; FRENCH SW
- Journal article: MOLECULAR PHARMACOLOGY. 1994;46(3):452-459JOHANSSON I; OSCARSON M; YUE QY; BERTILSSON L; SJOQVIST F; INGELMANSUNDBERG M
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1994;269(28):18378-18383ELIASSON E; MKRTCHIAN S; HALPERT JR; INGELMANSUNDBERG M
- Journal article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1994;269(3):1286-1291HU Y; MISHIN V; JOHANSSON I; VONBAHR C; CROSS A; RONIS MJJ; BADGER TM; INGELMANSUNDBERG M
- Journal article: ALCOHOL AND ALCOHOLISM (OXFORD, OXFORDSHIRE). SUPPLEMENT. 1994;2:131-139Ingelman-Sundberg M; Ronis MJ; Lindros KO; Eliasson E; Zhukov A
- Journal article: EXS. 1994;71:197-207Ingelman-Sundberg M; Johansson I; Persson I; Oscarson M; Hu Y; Bertilsson L; Dahl ML; Sjöqvist F
- Journal article: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 1994;233:117-127ALBANO E; TOMASI A; INGELMANSUNDBERG M
- Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1993;90(24):11825-11829JOHANSSON I; LUNDQVIST E; BERTILSSON L; DAHL ML; SJOQVIST F; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1993;46(11):1945-1951LONGO V; INGELMANSUNDBERG M
- Journal article: PHARMACOGENETICS AND GENOMICS. 1993;3(6):275-280MASIMIREMBWA CM; JOHANSSON I; HASLER JA; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1993;197(1):221-228ZHUKOV A; WERLINDER V; INGELMANSUNDBERG M
- Journal article: ALCOHOL. 1993;10(6):459-464MORIMOTO M; HAGBJORK AL; NANJI AA; INGELMANSUNDBERG M; LINDROS KO; FU PC; ALBANO E; FRENCH SW
- Journal article: ALCOHOL. 1993;10(6):453-457BADGER TM; RONIS MJJ; INGELMANSUNDBERG M; HAKKAK R
- Journal article: ALCOHOL. 1993;10(6):447-452INGELMANSUNDBERG M; JOHANSSON I; YIN H; TERELIUS Y; ELIASSON E; CLOT P; ALBANO E
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1993;45(10):1989-1994EKSTROM G; CRONHOLM T; NORSTENHOOG C; INGELMANSUNDBERG M
- Journal article: PHARMACOGENETICS AND GENOMICS. 1993;3(2):94-100BERTILSSON L; MEESE CO; YUE QY; DAHL ML; INGELMANSUNDBERG M; JOHANSSON I; SAWE J; EICHELBAUM M
- Journal article: EXPERIMENTAL AND MOLECULAR PATHOLOGY. 1993;58(1):61-75FRENCH SW; WONG K; JUI L; ALBANO E; HAGBJORK AL; INGELMANSUNDBERG M
- Journal article: INTERNATIONAL JOURNAL OF CANCER. 1993;53(3):395-400HOUDE M; DEBRUYNE G; BRACKE M; INGELMANSUNDBERG M; SKOGLUND G; MASURE S; VANDAMME J; OPDENAKKER G
- Journal article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1993;264(2):944-950RONIS MJJ; HUANG JA; CROUCH J; MERCADO C; IRBY D; VALENTINE CR; LUMPKIN CK; INGELMANSUNDBERG M; BADGER TM
- Journal article: LANCET. 1993;341(8836):63BERTILSSON L; DAHL ML; SJOQVIST F; ABERGWISTEDT A; HUMBLE M; JOHANSSON I; LUNDQVIST E; INGELMANSUNDBERG M
- Journal article: NORDIC JOURNAL OF PSYCHIATRY. 1993;47(sup30):27-31Dahl M-L; Bertilsson L; Ingelman-sundberg M; Johansson I; Lundqvist E; Sjöqvtst F
- Journal article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 1993;44(5):445-450DAHL ML; ISELIUS L; ALM C; SVENSSON JO; LEE D; JOHANSSON I; INGELMANSUNDBERG M; SJOQVIST F
- Journal article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1993;264(1):438-447BADGER TM; RONIS MJJ; LUMPKIN CK; VALENTINE CR; SHAHARE M; IRBY D; HUANG JA; MERCADO C; THOMAS P; INGELMANSUNDBERG M; CROUCH J
- Journal article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 1992;71(6):416-419HANSSON T; VONBAHR C; MARKLUND M; SVENSSON JO; INGELMANSUNDBERG M; LUNDSTROM J
- Journal article: PHARMACOGENETICS AND GENOMICS. 1992;2(6):264-271INGELMANSUNDBERG M; JOHANSSON I; PERSSON I; YUE QY; DAHL ML; BERTILSSON L; SJOQVIST F
- Journal article: ACTA PHYSIOLOGICA. 1992;146(1):135-140MENDEZ CF; HANSSON A; SKOGLUND G; INGELMANSUNDBERG M; APERIA A
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1992;267(22):15765-15769ELIASSON E; MKRTCHIAN S; INGELMANSUNDBERG M
- Journal article: JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY. 1992;3(Supplement):42-43Ingelman-Sundberg M; Eliasson E; Mkrtchian S; Ronis MJJ; Nordling A; Hagbjörk A-L; Wallblom A; Halpert J
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1992;43(11):2421-2426SHAN XQ; AW TY; SMITH ER; INGELMANSUNDBERG M; MANNERVIK B; IYANAGI T; JONES DP
- Journal article: LAKARTIDNINGEN. 1992;89(19):1675-1678Ingelman-Sundberg M; Johansson I; Dahl ML; Bertilsson L; Yue QY; Sjöqvist F
- Journal article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 1992;70(5):347-352TAKAHASHI H; JOHANSSON I; FRENCH SW; INGELMANSUNDBERG M
- Journal article: DRUG METABOLISM AND DISPOSITION. 1992;20(2):137-141SCHRENK D; INGELMANSUNDBERG M; BOCK KW
- Journal article: FEBS JOURNAL. 1992;204(1):407-412BUHLER R; LINDROS KO; NORDLING A; JOHANSSON I; INGELMANSUNDBERG M
- Journal article: FEBS JOURNAL. 1992;204(1):353-357CRONHOLM T; NORSTENHOOG C; EKSTROM G; HANDLER JA; THURMAN RG; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1992;43(3):567-573RONIS MJJ; LUMPKIN CK; THOMAS PE; INGELMANSUNDBERG M; BADGER TM
- Journal article: CLINICAL NEUROPHARMACOLOGY. 1992;15 Suppl 1 Pt A:88A-89ADahl ML; Johansson I; Yue QY; Säwe J; Bertilsson L; Ingelman-Sundberg M; Sjöqvist F
- Journal article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 1992;51(1):12-17DAHL ML; JOHANSSON I; PALMERTZ MP; INGELMANSUNDBERG M; SJOQVIST F
- Journal article: CARCINOGENESIS. 1991;12(12):2353-2356KOBUSCH AB; SCHRENK D; GANS G; MUNZEL P; WERRINGLOER J; INGELMANSUNDBERG M; BOCK KW
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1991;179(1):689-694TERELIUS Y; NORSTENHOOG C; CRONHOLM T; INGELMANSUNDBERG M
- Journal article: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 1991;15(4):693-699RONIS MJJ; LUMPKIN CK; INGELMANSUNDBERG M; BADGER TM
- Journal article: LAKARTIDNINGEN. 1991;88(28-29):2454-2457Ingelman-Sundberg M; Eliasson E; Johansson I
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1991;41(12):1895-1902ALBANO E; TOMASI A; PERSSON JO; TERELIUS Y; GORIAGATTI L; INGELMANSUNDBERG M; DIANZANI MU
- Journal article: BIOCHEMICAL JOURNAL. 1991;276(Pt 3):753-757INGELMANSUNDBERG M; KAUR H; TERELIUS Y; PERSSON JO; HALLIWELL B
- Journal article: FEBS JOURNAL. 1991;198(2):383-389RONIS MJJ; JOHANSSON I; HULTENBY K; LAGERCRANTZ J; GLAUMANN H; INGELMANSUNDBERG M
- Journal article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 1991;68(6):456-463MIKALSEN A; ALEXANDER J; ANDERSEN RA; INGELMANSUNDBERG M
- Journal article: CARCINOGENESIS. 1991;12(5):825-831MIKALSEN A; ALEXANDER J; WALLIN H; INGELMANSUNDBERG M; ANDERSEN RA
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1991;174(1):37-42JOHANSSON I; ELIASSON E; INGELMANSUNDBERG M
- Journal article: FREE RADICAL BIOLOGY AND MEDICINE. 1991;10(6):439-441HALLIWELL B; KAUR H; INGELMANSUNDBERG M
- Journal article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 1991;40(6):553-556JOHANSSON I; YUE QY; DAHL ML; HEIM M; SAWE J; BERTILSSON L; MEYER UA; SJOQVIST F; INGELMANSUNDBERG M
- Journal article: ALCOHOL AND ALCOHOLISM (OXFORD, OXFORDSHIRE). SUPPLEMENT. 1991;1:311-315BUHLER R; LINDROS KO; VONBOGUSLAWSKY K; KARKKAINEN P; MAKINEN J; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1990;173(1):331-338JOHANSSON I; LINDROS KO; ERIKSSON H; INGELMANSUNDBERG M
- Journal article: XENOBIOTICA. 1990;20(9):887-900PERSSON JO; TERELIUS Y; INGELMANSUNDBERG M
- Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1990;87(8):3225-3229ELIASSON E; JOHANSSON I; INGELMANSUNDBERG M
- Journal article: CARCINOGENESIS. 1990;11(3):489-492WALLIN H; MIKALSEN A; GUENGERICH FP; INGELMANSUNDBERG M; SOLBERG KE; ROSSLAND OJ; ALEXANDER J
- Journal article: NEUROSCIENCE. 1990;34(2):451-463HANSSON T; TINDBERG N; INGELMANSUNDBERG M; KOHLER C
- Journal article: FREE RADICAL BIOLOGY AND MEDICINE. 1990;9:163Albano E; Tomasi A; Ingelman-Sundberg M
- Journal article: LANCET. 1989;2(8678-9):1534YUE QY; BERTILSSON L; DAHLPUUSTINEN ML; SAWE J; SJOQVIST F; JOHANSSON I; INGELMANSUNDBERG M
- Journal article: LANCET. 1989;2(8678-8679):1534-1535Caporaso N; Pickle L
- Journal article: LANCET. 1989;2(8667):870YUE QY; BERTILSSON L; DAHLPUUSTINEN ML; SAWE J; SJOQVIST F; JOHANSSON I; INGELMANSUNDBERG M
- Journal article: XENOBIOTICA. 1989;19(10):1161-1165RONIS MJJ; INGELMANSUNDBERG M
- Journal article: BIOCHEMISTRY. 1989;28(10):4499-4504TINDBERG N; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1989;38(8):1313-1319EKSTROM G; INGELMANSUNDBERG M
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1989;264(10):5593-5597NORSTEN C; CRONHOLM T; EKSTROM G; HANDLER JA; THURMAN RG; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1989;38(4):689-693EKSTROM G; VONBAHR C; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1988;157(2):443-449SKOGLUND G; COTGREAVE I; RINCON J; PATARROYO M; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1988;157(1):55-60INGELMANSUNDBERG M; JOHANSSON I; PENTTILA KE; GLAUMANN H; LINDROS KO
- Journal article: CANCER RESEARCH. 1988;48(19):5387-5390JOHANSSON I; INGELMANSUNDBERG M
- Journal article: INTERNATIONAL JOURNAL OF CANCER. 1988;42(2):284-288FORSBECK K; NILSSON K; NYGREN P; LARSSON R; GYLFE E; SKOGLUND G; INGELMANSUNDBERG M
- Journal article: CANCER RESEARCH. 1988;48(11):3168-3172SKOGLUND G; PATARROYO M; FORSBECK K; NILSSON K; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1988;37(7):1383-1389TERELIUS Y; INGELMANSUNDBERG M
- Journal article: BIOCHEMISTRY. 1988;27(6):1925-1934JOHANSSON I; EKSTROM G; SCHOLTE B; PUZYCKI D; JORNVALL H; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1988;150(2):526-531HANSSON A; SKOGLUND G; LASSING I; LINDBERG U; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1988;150(1):436-443ELIASSON E; JOHANSSON I; INGELMANSUNDBERG M
- Journal article: BIOCHEMISTRY. 1987;26(23):7348-7354EKSTROM G; NORSTEN C; CRONHOLM T; INGELMANSUNDBERG M
- Journal article: CHEMINFORM. 1987;18(41):noHANSSON A; INGELMAN‐SUNDBERG M
- Journal article: ACTA CHEMICA SCANDINAVICA. 1987;41(3):174-179HANSSON A; INGELMANSUNDBERG M
- Journal article: FEBS JOURNAL. 1986;161(2):303-308TERELIUS Y; INGELMANSUNDBERG M
- Journal article: FEBS JOURNAL. 1986;158(1):195-201EKSTROM G; INGELMANSUNDBERG M
- Journal article: ACTA CHEMICA SCANDINAVICA. 1986;40(3):233-234INGELMANSUNDBERG M; PAUL KG
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1986;134(3):1215-1222HANSSON A; SERHAN CN; HAEGGSTROM J; INGELMANSUNDBERG M; SAMUELSSON B; MORRIS J
- Journal article: FEBS LETTERS. 1986;196(1):59-64JOHANSSON I; ELIASSON E; NORSTEN C; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL JOURNAL. 1986;233(3):755-761EKSTROM G; CRONHOLM T; INGELMANSUNDBERG M
- Journal article: CANCER RESEARCH. 1985;45(12):6194-6199FORSBECK K; NILSSON K; HANSSON A; SKOGLUND G; INGELMANSUNDBERG M
- Journal article: FEBS JOURNAL. 1985;151(1):97-100HANSSON A; INGELMANSUNDBERG M
- Journal article: FEBS JOURNAL. 1985;148(3):407-412SKOGLUND G; HANSSON A; INGELMANSUNDBERG M
- Journal article: FEBS LETTERS. 1985;183(2):265-269JOHANSSON I; INGELMANSUNDBERG M
- Journal article: ACTA PHARMACOLOGICA ET TOXICOLOGICA. 1985;56(1):69-74LUTHMAN H; INGELMANSUNDBERG M
- Journal article: ACTA CHEMICA SCANDINAVICA. 1985;39(3):219-226SKOGLUND G; HANSSON A; INGELMANSUNDBERG M
- Journal article: MEDICAL EDUCATION. 1985;19(1):34-42MARTENSON D; ERIKSSON H; INGELMANSUNDBERG M
- Journal article: ACTA CHEMICA SCANDINAVICA. 1985;39b:131-139Joela H; Salo E; Ingelman-Sundberg M; Gallagher J; Datema R; Chattopadhyaya J
- Journal article: FEBS JOURNAL. 1984;144(3):509-513BLANCK J; SMETTAN G; RISTAU O; INGELMANSUNDBERG M; RUCKPAUL K
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1984;124(2):375-382INGELMANSUNDBERG M; JORNVALL H
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1984;33(15):2521-2523EKSTROM G; INGELMANSUNDBERG M
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1984;259(10):6447-6458INGELMANSUNDBERG M; JOHANSSON I
- Journal article: ACTA CHEMICA SCANDINAVICA. 1984;38(10):845-851INGELMANSUNDBERG M; JOHANSSON I
- Journal article: FEBS JOURNAL. 1983;134(1):157-162INGELMANSUNDBERG M; BLANCK J; SMETTAN G; RUCKPAUL K
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1983;258(12):7311-7316JOHANSSON I; INGELMANSUNDBERG M
- Journal article: ACTA CHEMICA SCANDINAVICA. 1983;37(10):891-894BACKSTROM D; INGELMANSUNDBERG M; EHRENBERG A
- Journal article: XENOBIOTICA. 1982;12(11):673-686INGELMANSUNDBERG M; HAGBJORK AL
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1982;106(2):625-631INGELMANSUNDBERG M; EKSTROM G
- Journal article: ACTA PHARMACOLOGICA ET TOXICOLOGICA. 1982;50(4):251-260EKSTROM G; VONBAHR C; GLAUMANN H; INGELMANSUNDBERG M
- Journal article: BIOCHEMISTRY. 1981;20(14):4100-4106INGELMANSUNDBERG M; HAAPARANTA T; RYDSTROM J
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1981;256(12):6321-6326INGELMANSUNDBERG M; JOHANSSON I
- Journal article: BIOCHEMICAL SOCIETY TRANSACTIONS. 1981;9(2):117pIngelman-Sundberg M; Edvardsson A-L; Holmqvist A; Malmberg K
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1980;97(2):582-589INGELMANSUNDBERG M; JOHANSSON I
- Journal article: BIOCHEMISTRY. 1980;19(17):4004-4011INGELMANSUNDBERG M; JOHANSSON I
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1980;95(1):431-439BRUNSTROM A; INGELMANSUNDBERG M
- Journal article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1980;599(2):417-435INGELMANSUNDBERG M; GLAUMANN H
- Journal article: ACTA PHARMACOLOGICA ET TOXICOLOGICA. 1980;46(5):353-361TOFTGARD R; NILSEN OG; INGELMANSUNDBERG M; GUSTAFSSON JA
- Journal article: TRENDS IN PHARMACOLOGICAL SCIENCES. 1980;1(7):176-179INGELMANSUNDBERG M
- Journal article: ACTA BIOLOGICA ET MEDICA GERMANICA. 1979;38(2-3):275-285RYDSTROM J; INGELMANSUNDBERG M; MONTELIUS J; GUSTAFSSON JA
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1979;254(15):7434-7441HALPERT J; GLAUMANN H; INGELMANSUNDBERG M
- Journal article: BIOMEDICAL MASS SPECTROMETRY. 1979;6(8):317-324RAFTER JJ; INGELMANSUNDBERG M; GUSTAFSSON JA
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1979;254(12):5264-5271BERG A; INGELMANSUNDBERG M; GUSTAFSSON JA
- Journal article: ACTA BIOLOGICA ET MEDICA GERMANICA. 1979;38(2-3):333-344BERG A; INGELMANSUNDBERG M; GUSTAFSSON JA
- Journal article: ACTA BIOLOGICA ET MEDICA GERMANICA. 1979;38(2-3):379-388INGELMANSUNDBERG M; JOHANSSON I; HANSSON A
- Journal article: BIOCHEMICAL PHARMACOLOGY. 1979;28(4):497-499GUSTAFSSON JA; INGELMANSUNDBERG M
- Journal article: TRENDS IN PHARMACOLOGICAL SCIENCES. 1979;1(1):176-179Ingelman-Sundberg M
- Journal article: ACTA BIOLOGICA ET MEDICA GERMANICA. 1979;38(2-3):321-331RAFTER JJ; INGELMANSUNDBERG M; GUSTAFSSON JA
- Journal article: ACTA PHARMACOLOGICA ET TOXICOLOGICA. 1978;43(4):299-305NILSEN OG; TOFTGARD R; INGELMANSUNDBERG M; GUSTAFSSON JA
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1978;253(14):5042-5047INGELMANSUNDBERG M; MONTELIUS J; RYDSTROM J; GUSTAFSSON JA
- Journal article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1977;488(3):502-511MONTELIUS J; GUSTAFSSON JA; INGELMANSUNDBERG M; RYDSTROM J
- Journal article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1977;488(2):225-234INGELMANSUNDBERG M
- Journal article: FEBS LETTERS. 1977;74(1):103-106INGELMANSUNDBERG M; GUSTAFSSON JA
- Journal article: FEBS LETTERS. 1977;78(1):72-76INGELMANSUNDBERG M; GLAUMANN H
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1976;73(3):555-561RYDSTROM J; GUSTAFSSON JA; INGELMANSUNDBERG M; MONTELIUS J; ERNSTER L
- Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1976;43(1):56-63EINARSSON K; GUSTAFSSON JA; IHRE T; INGELMANSUNDBERG M
- Journal article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1976;431(3):592-602INGELMANSUNDBERG M
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1976;251(9):2831-2838BERG A; GUSTAFSSON JA; INGELMANSUNDBERG M; CARLSTROM K
- Journal article: FEBS JOURNAL. 1976;64(1):35-43GUSTAFSSON JA; INGELMANSUNDBERG M
- Journal article: ENDOCRINOLOGY. 1976;98(4):922-926GUSTAFSSON JA; INGELMANSUNDBERG M; STENBERG A; HOKFELT T
- Journal article: FEBS JOURNAL. 1976;61(1):43-52HRYCAY EG; GUSTAFSSON JA; INGELMANSUNDBERG M; ERNSTER L
- Journal article: BIOCHEMICAL SOCIETY TRANSACTIONS. 1975;3(6):977INGELMANSUNDBERG M; GUSTAFSSON JA
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1975;66(4):1414-1423BERG A; CARLSTROM K; GUSTAFSSON JA; INGELMANSUNDBERG M
- Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1975;66(1):209-216HRYCAY EG; GUSTAFSSON JA; INGELMANSUNDBERG M; ERNSTER L
- Journal article: FEBS LETTERS. 1975;56(1):161-165HRYCAY EG; GUSTAFSSON JA; INGELMANSUNDBERG M; ERNSTER L
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1975;250(9):3451-3458GUSTAFSSON JA; INGELMANSUNDBERG M
- Journal article: JOURNAL OF STEROID BIOCHEMISTRY. 1975;6(5):643-649GUSTAFSSON JA; INGELMANSUNDBERG M; STENBERG A
- Journal article: JOURNAL OF ENDOCRINOLOGY. 1975;64(2):267-275GUSTAFSSON JA; INGELMANSUNDBERG M; STENBERG A; NEUMANN F
- Journal article: BIOCHEMISTRY. 1975;14(2):429-437INGELMANSUNDBER M; RANE A; GUSTAFSSON JA
- Journal article: JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 1974;5(8):855-859GUSTAFSSON JA; GUSTAFSSON SA; INGELMANSUNDBERG M; POUSETTE A; STENBERG A; WRANGE O
- Journal article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1974;354(2):172-181Gustafsson JA; Ingelman-Sundberg M
- Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1974;249(6):1940-1945Gustafsson JA; Ingelman-Sundberg M
- Journal article: FEBS LETTERS. 1973;31(3):292-296Gustafsson JA; Ingelman-Sundberg M
- Visa fler
Alla övriga publikationer
- Review: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2025;91(6):1569-1579Ingelman-Sundberg M; Molden E
- Editorial comment: WORLD PSYCHIATRY. 2025;24(1):141-142van Westrhenen R; Young AH; Heilbronner U; Juruena M; Ingelman-Sundberg M; Jukic M; Kaprio J; Kas MJH; Moldovan R; Nothen MM; Philipsen A; Shomron N; van der Eycken E; Vieta E; Schulze TG; PSY PC
- Review: PHARMACOLOGICAL REVIEWS. 2024;76(6):1089-1101Weitzberg E; Ingelman-Sundberg M; Lundberg JO; Engberg G; Schulte G; Lauschke VM
- Editorial comment: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2024;116(4):899-901Ingelman-Sundberg M
- Letter: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024;84:16-17van Westrhenen R; Ingelman-Sundberg M
- Review: DRUG METABOLISM AND DISPOSITION. 2024;52(6):467-475Ingelman-Sundberg M; Lauschke VM
- Review: JOURNAL OF INTERNAL MEDICINE. 2024;295(5):583-598Ingelman-Sundberg M; Pirmohamed M
- Review: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024;81:43-52Milosavljevic F; Molden E; Ingelman-Sundberg M; Jukic MM
- Letter: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2024;115(2):183Ingelman-Sundberg M; Jukic M; Braten LS; Kringen MK; Molden E
- Review: ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. 2024;64:33-51Lauschke VM; Zhou Y; Ingelman-Sundberg M
- Editorial comment: HUMAN GENOMICS. 2023;17(1):105Ingelman-Sundberg M; Nebert DW; Lauschke VM
- Letter: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2022;112(6):1155Pridgeon CS; Johansson I; Ingelman-Sundberg M
- Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2022;43(12):1055-1069Jukic M; Milosavljevi F; Molden E; Ingelman-Sundberg M
- Editorial comment: TRENDS IN PHARMACOLOGICAL SCIENCES. 2022;43(12):987-993Ingelman-Sundberg M; Cadet JL; Gobbi G; Olson DE; Yohn S; Foster DJ
- Preprint: BIORXIV. 2022Järvinen E; Hammer HS; Pötz O; Ingelman-Sundberg M; Stage TB
- Editorial comment: PHARMACOGENOMICS. 2022;23(8):453-455Ingelman-Sundberg M
- Preprint: BIORXIV. 2022Milosavljević F; Brusini I; Atanasov A; Manojlović M; Novalen M; Vučić M; Dušić ZO; Brkljačić J; Miksys S; Miljević Č; Nikolić A; Blagojević D; Wang C; Damberg P; Pešić V; Tyndale RF; Ingelman-Sundberg M; Jukić MM
- Review: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2022;130:5-15Ingelman-Sundberg M; Lauschke VM
- Editorial comment: FRONTIERS IN PHARMACOLOGY. 2021;12:725565van Westrhenen R; Ingelman-Sundberg M
- Conference publication: TOXICOLOGY LETTERS. 2021;350:S29Ingelman-Sundberg M
- Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(15):8221Harjumaki R; Pridgeon CS; Ingelman-Sundberg M
- Conference publication: FEBS OPEN BIO. 2021;11:39Ingelman-Sundberg M
- Review: JAMA PSYCHIATRY. 2021;78(3):270-280Milosavljevic F; Bukvic N; Pavlovic Z; Miljevic C; Pesic V; Molden E; Ingelman-Sundberg M; Leucht S; Jukic MM
- Review: ARCHIVES OF TOXICOLOGY. 2021;95(1):11-25Smutny T; Hyrsova L; Braeuning A; Ingelman-Sundberg M; Pavek P
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;40:S208Milosavljevic F; Vucic M; Manojlovic M; Milosevski T; Batinic B; Novalen M; Miksys S; Tyndale F R; Ingelman-Sundberg M; Pesic V; Jukic M M
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;40:S250-S251Milosavljevic F; Bukvic N; Pavlovic Z; Miljevic C; Pesic V; Molden E; Ingelman-Sundberg M; Leucht S; Jukic M
- Review: FRONTIERS IN PHARMACOLOGY. 2020;11:575540van Schaik RHN; Muller DJ; Serretti A; Ingelman-Sundberg M
- Letter: TRENDS IN PHARMACOLOGICAL SCIENCES. 2020;41(8):503-506Ingelman-Sundberg M; Lauschke VM
- Published conference paper: CHEMICO-BIOLOGICAL INTERACTIONS. 2020;325:109131Ronis MJ; Mercer KE; Shankar K; Pulliam C; Pedersen K; Ingelman-Sundberg M; Friso S; Samuelson D; Del Valle L; Taylor C; Welsh DA
- Review: FRONTIERS IN PSYCHIATRY. 2020;11:94van Westrenhen R; Aitchison KJ; Ingelman-Sundberg M; Jukic MM
- Review: NPJ GENOMIC MEDICINE. 2020;5(1):9Lauschke VM; Ingelman-Sundberg M
- Preprint: BIORXIV. 2020van der Lee M; Allard WG; Vossen RHAM; Baak-Pablo RF; Menafra R; Deiman BALM; Deenen MJ; Neven P; Johansson I; Gastaldello S; Ingelman-Sundberg M; Guchelaar H-J; Swen JJ; Anvar SY
- Editorial comment: PHARMACOLOGICAL RESEARCH. 2020;153:104620Ingelman-Sundberg M
- Review: NATURE REVIEWS DRUG DISCOVERY. 2020;19(2):131-148Weaver RJ; Blomme EA; Chadwick AE; Copple IM; Gerets HHJ; Goldring CE; Guillouzo A; Hewitt PG; Ingelman-Sundberg M; Jensen KG; Juhila S; Klingmuller U; Labbe G; Liguori MJ; Lovatt CA; Morgan P; Naisbitt DJ; Pieters RHH; Snoeys J; van de Water B; Williams DP; Park BK
- Letter: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2020;126(1):7-8van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar H-J
- Conference publication: NEUROPSYCHOPHARMACOLOGY. 2019;44(SUPPL 1):139Milosavljevic F; Bukvic N; Pesic V; Pavlovic Z; Miljevic C; Molden E; Ingelman-Sundberg M; Jukic M
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S399-S400Milosavljevic F; Vucic M; Manojlovic M; Asujic N; Batinic B; Novalen M; Miksys S; Tyndale RF; Ingelman-Sundberg M; Jukic MM
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S322Jukic M; Smith RL; Haslemo T; Moleden E; Ingelman-Sundberg M
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S17Milosavljevic F; Vucic M; Manojlovic M; Asujic N; Batinic B; Novalen M; Miksys S; Tyndale RF; Ingelman-Sundberg M; Pesic V; Jukic M
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S533-S534Milosavljevic F; Bukvic N; Pesic V; Molden E; Ingelman-Sundberg M; Jukic M
- Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2019;27:1070-1071Ingelman-Sundberg M; Ingelman-Sundberg M
- Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2019;27:545-546Santos M; Niemi M; Hiratsuka M; Kumondai M; Ingelman-Sundberg M; Lauschke VM; Rodriguez-Antona C
- Review: BIOTECHNOLOGY JOURNAL. 2019;14(7):e1800347Lauschke VM; Shafagh RZ; Hendriks DFG; Ingelman-Sundberg M
- Review: PHARMACOLOGY & THERAPEUTICS. 2019;197:122-152Lauschke VM; Zhou Y; Ingelman-Sundberg M
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S672-S673Milosavljevi F; Vucic M; Manojlovic M; Asujic N; Batinic B; Novalen M; Miksys S; Tyndale R; Ingelman-Sundberg M; Pesic V; Jukic M
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:1030Ingelman-Sundberg M
- Letter: TOXICOLOGICAL SCIENCES. 2018;165(1):4-5Ingelman-Sundberg M; Lauschke VM
- Conference publication: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2018;123:89Santos M; Niemi M; Hiratsuka M; Kumondai M; Ingelman-Sundberg M; Lauschke VM; Rodriguez-Antona C
- Conference publication: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2018;123:8Haslemo T; Eliasson E; Jukic M; Ingelman-Sundberg M; Molden E
- Review: ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. 2018;58:161-185Lauschke VM; Barragan I; Ingelman-Sundberg M
- Review: ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. 2018;58:65-82Ewart L; Dehne E-M; Fabre K; Gibbs S; Hickman J; Hornberg E; Ingelman-Sundberg M; Jang K-J; Jones DR; Lauschke VM; Marx U; Mettetal JT; Pointon A; Williams D; Zimmermann W-H; Newham P
- Conference publication: PUBLIC HEALTH GENOMICS. 2018;21:3Ingelman-Sundberg M
- Review: AAPS JOURNAL. 2017;20(1):4Lauschke VM; Milani L; Ingelman-Sundberg M
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S856Jukic M; Molden E; Ingelman-Sundberg M
- Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2017;38(9):765-770Lauschke VM; Ivanov M; Ingelman-Sundberg M
- Review: HEPATOLOGY. 2017;65(2):710-721Goldring C; Antoine DJ; Bonner F; Crozier J; Denning C; Fontana RJ; Hanley NA; Hay DC; Ingelman-Sundberg M; Juhila S; Kitteringham N; Silva-Lima B; Norris A; Pridgeon C; Ross JA; Young RS; Tagle D; Tornesi B; de Water BV; Weaver RJ; Zhang F; Park BK
- Book chapter: COMPREHENSIVE MEDICINAL CHEMISTRY III. 2017;p. 217-238Goldring C; Weaver R; Kramer B; Klingmueller U; Oppelt A; Van der Water B; Commandeur J; Guillouzo A; Naisbitt D; French N; Kitteringham N; Pridgeon C; Knolle P; Sidaway J; Sison-Young R; Kamalian L; Mercer A; Faulkner L; Pieters R; Ingelman-Sundberg M; Park BK
- Review: CHEMICAL RESEARCH IN TOXICOLOGY. 2016;29(12):1936-1955Lauschke VM; Hendriks DFG; Bell CC; Andersson TB; Ingelman-Sundberg M
- Review: ARCHIVES OF TOXICOLOGY. 2016;90(12):2979-3003Dragovic S; Vermeulen NPE; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
- Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2016;17(10):E1714-1714Lauschke VM; Ingelman-Sundberg M
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2016;26:S379-S380Jukic M; Opel N; Strom J; Carrillo-Roa T; Miksys S; Novalen M; Renblom A; Sim S; Penas-Lledo E; Courtet P; Llerena A; Papassotiropoulos A; Tyndale R; Binder E; Dannlowski U; Ingelman-Sundberg M
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2016;26:S119Ingelman-Sundberg M
- Review: DRUG METABOLISM REVIEWS. 2016;48(3):369-378Guo J; Johansson I; Mkrtchian S; Ingelman-Sundberg M
- Editorial comment: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2016;99(5):478-480Ingelman-Sundberg M; Cascorbi I
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2016;26:S59-S60Opel N; Jukic M; Ingelman-Sundberg M; Dannlowski U
- Editorial comment: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2016;75:1-4Nebert DW; Ingelman-Sundberg M
- Editorial comment: TRENDS IN PHARMACOLOGICAL SCIENCES. 2016;37(2):85-86Lauschke VM; Ingelman-Sundberg M
- Conference publication: PUBLIC HEALTH GENOMICS. 2016;19:6-7Ingelman-Sundberg M
- Conference publication: NEUROPSYCHOPHARMACOLOGY. 2015;40:S143Koola M; Tandon K; Kinirons M; Ingelman-Sundberg M; Gill M; McGuffin P; Kerwin R; Aitchison K
- Conference publication: TRANSPLANTATION. 2015;99(11):S252-S253Watanabe M; Moro S; Jorns C; Mork L-M; Ingelman-Sundberg M; Ellis E
- Conference publication: XENOTRANSPLANTATION. 2015;22:S154Watanabe M; Moro S; Jorns C; Mork L-M; Ingelman-Sundberg M; Ellis E
- Conference publication: TOXICOLOGY LETTERS. 2015;238(2):S184Messner S; Puigvert LF; Escher C; Bober M; Roessger K; Kelm JM; Moritz W; Ingelman-Sundberg M
- Conference publication: TOXICOLOGY LETTERS. 2015;238(2):S30Ingelman-Sundberg M; Puigvert LF; Klein S; Peters P; Moro S; Bell C; Hendriks D; Muller D; Schweitzer V; Noor F; Heinzle E
- Conference publication: TOXICOLOGY LETTERS. 2015;238(2):S31Terfloth L; Bucher J; Klein S; Tascher G; Johansson I; Magioni S; Bertile F; Ingelman-Sundberg M; van Dorsselaer A; Benfenati E; Noor F; Heinzle E; Mauch K
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2015;25:S553-S554Jukic MM; Penas-Lledo E; Courtet P; Llerena A; Ingelman-Sundberg M
- Review: STEM CELLS AND DEVELOPMENT. 2015;24(11):1284-1296Suter-Dick L; Alves PM; Blaauboer BJ; Bremm K-D; Brito C; Coecke S; Flick B; Fowler P; Hescheler J; Ingelman-Sundberg M; Jennings P; Kelm JM; Manou I; Mistry P; Moretto A; Roth A; Stedman D; van de Water B; Beilmann M
- Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2015;277(2):152-154Ingelman-Sundberg M
- Other: PHARMACOGENOMICS. 2015;16(14):1527-1539Siest G; Auffray C; Taniguchi N; Ingelman-Sundberg M; Murray H; Visvikis-Siest S; Ansari M; Marc J; Jacobs P; Meyer U; Van Schaik RHN; Müller MM; Wevers RA; Simmaco M; Kussmann M; Manolopoulos VG; Alizadeh BZ; Beastall G; Németh G
- Conference publication: 2014;:6Ivanov M; Ingelman-Sundberg M; Kals M; Milani L
- Conference publication: EUROPEAN JOURNAL OF CANCER. 2014;50:95Pors K; Le Morvan V; Travica S; Shnyder SD; Sutherland M; Sheldrake HM; Searcey M; Johansson I; Mkrtchian S; Loadman PM; Robert J; Ingelman-Sundberg M; Patterson LH
- Conference publication: JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. 2014;70(3):328Agarkova I; Messner S; Zuppinger C; Gunness P; Moritz W; Hengstler JG; Ingelman-Sundberg M; Kelm JM
- Conference publication: CANCER RESEARCH. 2014;74(19):1779Pors K; Loadman PM; Travica S; Shnyder SD; Sutherland M; Sheldrake H; Searcey M; Johansson I; Mkrtchian S; Ingelman-Sundberg M; Patterson LH
- Conference publication: TOXICOLOGY LETTERS. 2014;229:S142-S143Moro S; Persson A; Bell C; Puigvert LF; Hendriks D; Sim S; Ingelman-Sundberg M
- Conference publication: TOXICOLOGY LETTERS. 2014;229:S144Gunness P; Messner S; Fredriksson L; Kelm J; Moritz W; Ingelman-Sundberg M
- Conference publication: TOXICOLOGY LETTERS. 2014;229:S38Ingelman-Sundberg M
- Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2014;35(8):384-396Ivanov M; Barragan I; Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2014;45:210Cavaco I; Edvardsen H; Ingelman-Sundberg M; Kristensen V; Sim S
- Conference publication: DRUG METABOLISM REVIEWS. 2014;45:208Cavaco I; Edvardsen H; Ingelman-sundberg M; Kristensen V; Sim S
- Editorial comment: PHARMACOGENOMICS. 2014;15(15):1841-1844Ingelman-Sundberg M; Persson A; Jukic MM
- Conference publication: JOURNAL OF NEUROCHEMISTRY. 2013;125:232Persson A; Sim SC; Virding S; Onishchenko N; Schulte G; Ingelman-Sundberg M
- Conference publication: FASEB JOURNAL. 2013;27:1102.4Lee JK; Chung HJ; Pan X; Ingelman-Sundberg M; Jeong H
- Review: PHARMACOGENOMICS JOURNAL. 2013;13(1):1-11Sim SC; Kacevska M; Ingelman-Sundberg M
- Editorial comment: PHARMACOGENOMICS. 2012;13(16):1887-1891Eliasson E; Sim SC; Rane A; Ingelman-Sundberg M
- Review: PHARMACOGENOMICS. 2012;13(12):1373-1385Kacevska M; Ivanov M; Ingelman-Sundberg M
- Book chapter: ENCYCLOPEDIA OF LIFE SCIENCES. 2011;p.Ingelman‐Sundberg M
- Review: HUMAN MUTATION. 2011;32(5):526-531Sim SC; Altman RB; Ingelman-Sundberg M
- Conference publication: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2011;89:S61Wu JC; Baldwin RM; Ingelman-Sundberg M; Rosenborg S; Yim DS; Yin OQ; Capparelli EV; Ma JD
- Conference publication: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2011;89:S57Lawson EB; Baldwin RM; Ingelman-Sundberg M; Rosenborg S; Yim DS; Yin OQ; Capparelli EV; Ma JD
- Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2011;32(2):72-81Sim SC; Ingelman-Sundberg M
- Review: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2010;34(6):1075-1084Kotsovolou O; Ingelman-Sundberg M; Lang MA; Marselos M; Overstreet DH; Papadopoulou-Daifoti Z; Johanson I; Fotopoulos A; Konstandi M
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2010;20:S172-S173Keers R; Ingelman-Sundberg M; Hauser J; Maier W; Rietschel M; Mors O; McGuffin P; Farmer AE; Craig IW; Aitchison KJ
- Conference publication: DRUG METABOLISM REVIEWS. 2010;42:82-83Sivertsson L; Ek M; Darnell M; Edebert I; Ingelman-Sundberg M; Neve EPA
- Conference publication: DRUG METABOLISM REVIEWS. 2010;42:26Ingelman-Sundberg M
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2010;20:S70-S71Keers R; Ingelman-Sundberg M; Hauser J; Maier W; Rietschel M; Mors O; McGuffin P; Farmer AE; Craig IW; Aitchison KJ
- Review: CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT. 2010;13(1):78-85Neve EPA; Ingelman-Sundberg M
- Review: HUMAN GENETICS. 2010;127(1):1-17Rodriguez-Antona C; Gomez A; Karlgren M; Sim SC; Ingelman-Sundberg M
- Conference publication: FEBS JOURNAL. 2009;276:25Ingelman-Sundberg M
- Review: PHARMACOGENOMICS. 2009;10(7):1067-1076Gomez A; Ingelman-Sundberg M
- Letter: PHARMACOGENETICS AND GENOMICS. 2009;19(7):565-566Sim SC; Miller WL; Zhong X-B; Arlt W; Ogata T; Ding X; Wolf CR; Flueck CE; Pandey AV; Henderson CJ; Porter TD; Daly AK; Nebert DW; Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2009;41:23Mwinyi J; Pedersen RS; Cavaco I; Persson A; Burkhardt S; Mkrtchian S; Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2009;41:32Sivertsson L; Monica E; Ingelman-Sundberg M; Neve EPA
- Conference publication: DRUG METABOLISM REVIEWS. 2009;41:12Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2009;41:55Edsbagge J; Kuppers-Munther B; Lindqvist J; Strom C; Brolen G; Heins N; Rehnstrom M; Athley L; Eriksson G; Jensen J; Ek M; Sivertsson L; Darnell M; Andersson TB; Johansson I; Ingelman-Sundberg M; Bjorquist P
- Review: DRUG DISCOVERY TODAY. 2009;14(7-8):401-405Huynh L; Masereeuw R; Friedberg T; Ingelman-Sundberg M; Manivet P
- Other: DRUG NEWS AND PERSPECTIVES. 2008;21(9):518-528Johansson I; Ingelman-Sundberg M
- Review: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2008;392(6):1075-1084Neve EPA; Ingelman-Sundberg M
- Editorial comment: NEW ENGLAND JOURNAL OF MEDICINE. 2008;358(6):637-639Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2008;40:109-110Sivertsson L; Edling Y; Butura A; Ingelman-Sundberg M; Ek M
- Conference publication: DRUG METABOLISM REVIEWS. 2008;40:30Mwinyi J; Pedersen RS; Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2008;40:29Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2008;40:98-99Kuppers-Munther B; Ek M; Edsbagge J; Heins N; Brolen G; Rehnstrom M; Athley E; Darnell M; Andersson TB; Johansson I; Ingelman-Sundberg M; Bjorquist P
- Review: PHARMACOLOGY & THERAPEUTICS. 2007;116(3):496-526Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
- Conference publication: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2007;101(5):361Ingelman-Sundberg M
- Conference publication: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2007;37:78-79Ingelman-Sundberg M
- Conference publication: GASTROENTEROLOGY. 2007;132(4):A814Seitz HK; Glassen K; Waldherr R; Stickel F; Ingelman-Sundberg M
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2007;13(2):70-71Afsharian P; Teredius Y; Hidestrand M; Ingelman-Sundberg M; Hassan M; Lundgren S
- Conference publication: NORDIC JOURNAL OF PSYCHIATRY. 2007;61(6):491-492Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2007;39:159-160Hiratsuka M; Hanzawa Y; Sasaki T; Sakuyama K; Ishikawa M; Mizugaki M; Karlgren M; Tachibana M; Gomez A; Ingelman-Sundberg M
- Review: EXPERT OPINION ON THERAPEUTIC TARGETS. 2007;11(1):61-67Karlgren M; Ingelman-Sundberg M
- Other: DRUG NEWS AND PERSPECTIVES. 2006;19(10):637-651Afzelius L; Ingelman-Sundberg M; Karlgren M; Rodriguez-Antona C
- Conference publication: AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS. 2006;141B(7):761-762Huezo-Diaz P; Williamson R; Nash MW; Sim SC; Alhberg S; Hoda F; Rietschel M; Schmal C; Farmer A; Schulze T; Hauser J; Henigsberg N; Maier W; Zobel A; Larsen ER; Mors O; Mendelewicz J; Marusic A; Perez J; Schalkwyk L; McGuffin P; Craig I; Ingelman-Sundberg M; Aitchison KJ
- Meeting abstract: TOXICOLOGY LETTERS. 2006;164:S7Ingelman-Sundberg M
- Letter: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2006;296(7):764-765Ingelman-Sundberg M; Sim SC; Nebert DW
- Conference publication: ACTA PHARMACOLOGICA SINICA. 2006;27:24Ingelman-Sundberg M
- Review: ONCOGENE. 2006;25(11):1679-1691Rodriguez-Antona C; Ingelman-Sundberg M
- Review: ATLA-ALTERNATIVES TO LABORATORY ANIMALS. 2006;34(1):49-84Coecke S; Ahr H; Blaauboer BJ; Bremer S; Casati S; Castell J; Combes R; Corvi R; Crespi CL; Cunningham ML; Elaut G; Eletti B; Freidig A; Gennari A; Ghersi-Egea JF; Guillouzo A; Hartung T; Hoet P; Ingelman-Sundberg M; Munn S; Janssens W; Ladstetter B; Leahy D; Long A; Meneguz A; Monshouwer M; Morath S; Nagelkerke F; Pelkonen O; Ponti J; Prieto P; Richert L; Sabbioni E; Schaack B; Steiling W; Testai E; Vericat JA; Worth A
- Review: ANNUAL REVIEW OF MEDICINE. 2006;57:119-137Eichelbaum M; Ingelman-Sundberg M; Evans WE
- Book chapter: ENCYCLOPEDIA OF LIFE SCIENCES. 2006;p.Ingelman‐Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2006;38:57-58Karlgren M; Gomez A; Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2006;38:4-5Ingelman-Sundberg M
- Published conference paper: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 2005;592(1-2):45-57Raimondi S; Boffetta P; Anttila S; Bröckmoller J; Butkiewicz D; Cascorbi I; Clapper ML; Dragani TA; Garte S; Gsur A; Haidinger G; Hirvonen A; Ingelman-Sundberg M; Kalina I; Lan Q; Leoni VP; Le Marchand L; London SJ; Neri M; Povey AC; Rannug A; Reszka E; Ryberg D; Risch A; Romkes M; Ruano-Ravina A; Schoket B; Spinola M; Sugimura H; Wu XF; Taioli E
- Review: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2005;338(1):299-305Rodríguez-Antona C; Sayi JG; Gustafsson LL; Bertilsson L; Ingelman-Sundberg M
- Review: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2005;207(2 Suppl):57-61Karlgren M; Miura S-I; Ingelman-Sundberg M
- Review: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2005;207(2 Suppl):52-56Ingelman-Sundberg M
- Published conference paper: PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2005;360(1460):1563-1570Ingelman-Sundberg M; Rodriguez-Antona C
- Review: PHARMACOGENOMICS JOURNAL. 2005;5(1):6-13Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2005;37:75Wang J; Sönnerborg A; Rane A; Lundgren S; Stahle L; Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2005;37:51Karlgren M; Stark K; Oliw E; Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2005;37:48-49Johansson I; Thelin A; Hofmann Y; Andersson S; Nordling A; Li QX; Carlsson SC; Andersson TB; Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2005;37:40Gomez A; Rodriguez-Antona C; Mkrtchian S; Karlgren M; Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2005;37:27-28Andersson S; Hofmann Y; Nordling A; Li XQ; Nivelius S; Andersson TB; Ingelman-Sundberg M; Johansson I
- Book chapter: ENCYCLOPEDIA OF MEDICAL GENOMICS AND PROTEOMICS. 2004;p. 323-327Ingelman‐Sundberg M
- Conference publication: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2004;31(11):A220Aklillu E; Carrillo JA; Mekonen E; Bertilsson L; Ingelman-Sundberg M
- Other: DRUG NEWS AND PERSPECTIVES. 2004;17(9):594-605Gomez A; Ingelman-Sundberg M; Johansson I; Karlgren M; Rodriguez-Antona C; Sim SC
- Meeting abstract: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2004;28(8):54AIngelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2004;36:320Butura A; Johansson I; Nilsson K; Wärngård L; Ingelman-Sundberg M; Schuppe-Koistinen I
- Conference publication: DRUG METABOLISM REVIEWS. 2004;36:101Andersson TB; Andersson S; Li XQ; Johansson I; Carlsson S; Ingelman-Sundberg M
- Conference publication: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2004;197(3):142Ingelman-Sundberg M
- Conference publication: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2004;197(3):142Karlgren M; Oscarson M; Ingelman-Sundberg M
- Review: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2004;79(6):935-945Larsson SC; Kumlin M; Ingelman-Sundberg M; Wolk A
- Conference publication: FASEB JOURNAL. 2004;18(8):C4Ingelman-Sundberg M
- Meeting abstract: JOURNAL OF HEPATOLOGY. 2004;40:163Vidali M; Hidestrand M; Mottaran E; Reale E; Rolla R; Occhino G; Ingelman-Sundberg M; Albano E
- Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2004;25(4):193-200Ingelman-Sundberg M
- Published conference paper: EXPERIMENTAL BIOLOGY AND MEDICINE. 2004;229(4):351-360Ronis MJJ; Hakkak R; Korourian S; Albano E; Yoon S; Ingelman-Sundberg M; Lindros KO; Badger TM
- Review: NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. 2004;369(1):89-104Ingelman-Sundberg M
- Conference publication: GLIA. 2003;:38Simi A; Edling Y; Ingelman-Sundberg M; Tindberg N
- Conference publication: GLIA. 2003;:37-38Edling Y; Simi A; Ingelman-Sundberg M; Tindberg N
- Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:5-6Ingelman-Sundberg M
- Conference publication: DRUG METABOLISM REVIEWS. 2003;35:19Ingelman-Sundberg M
- Published conference paper: TOXICOLOGY. 2002;181:447-452Ingelman-Sundberg M
- Conference publication: GLIA. 2002;:S47Simi A; Porsmyr-Palmertz M; Ingelman-Sundberg M; Tindberg N
- Review: BIOMARKERS. 2002;7(3):230-241Lee WJ; Brennan P; Boffetta P; London SJ; Benhamou S; Rannug A; To-Figueras J; Ingelman-Sundberg M; Shields P; Gaspari L; Taioli E
- Conference publication: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2002;71(2):P41Pitarque M; von Richter O; Oscarson M; Ingelman-Sundberg M
- Book chapter: WILEY ENCYCLOPEDIA OF MOLECULAR MEDICINE. 2002;p.Ingelman‐Sundberg M
- Review: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 2002;357:28-36Ingelman-Sundberg M; Oscarson M
- Letter: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2001;10(12):1307-1308Ingelman-Sundberg M; Oscarson M; Daly AK; Garte S; Nebert DW
- Corrigendum: PHARMACOGENETICS AND GENOMICS. 2001;11(8):743Wennerholm A; Johansson I; Hidestrand M; Bertilsson L; Gustafsson LL; IngelmanSundberg M
- Editorial comment: PHARMACOGENETICS AND GENOMICS. 2001;11(7):553-554Ingelman-Sundberg M; Evans WE
- Review: JOURNAL OF INTERNAL MEDICINE. 2001;250(3):186-200Ingelman-Sundberg M
- Conference publication: TOXICOLOGY. 2001;164(1-3):152Gullstén H; Sillanpää P; Anttila S; Oscarson M; McLellan RA; Rautio A; Ingelman-Sundberg M; Järvisalo J; Pelkonen O; Raunio H; Husgafvel-Pursiainen K; Hirvonen A
- Conference publication: TOXICOLOGY. 2001;164(1-3):33Ingelman-Sundberg M
- Published conference paper: ATLA-ALTERNATIVES TO LABORATORY ANIMALS. 2001;29(3):305-306Ingelman-Sundberg M
- Published conference paper: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2001;25(5):237S-243SSun AY; Ingelman-Sundberg M; Neve E; Matsumoto H; Nishitani Y; Minowa Y; Fukui Y; Bailey SM; Patel VB; Cunningham CC; Zima T; Fialova L; Mikulikova L; Popov P; Malbohan I; Janebova M; Nespor K; Sun GY
- Published conference paper: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2001;25(5):225S-229SFrench SW; Mayer RJ; Bardag-Gorce F; Ingelman-Sundberg M; Rouach H; Neve E; Higashitsuji H
- Conference publication: JOURNAL OF HEPATOLOGY. 2001;34:197Li J; Cortez-Pinto H; Waldherr R; Ingelman-Sundberg M; Baptista A; Camilo ME; Seitz HK
- Published conference paper: DRUG METABOLISM AND DISPOSITION. 2001;29(4):580-585Alvan G; Bertilsson L; Dahl ML; Ingelman-Sundberg M; Sjöqvist F
- Published conference paper: DRUG METABOLISM AND DISPOSITION. 2001;29(4):570-573Ingelman-Sundberg M
- Published conference paper: TOXICOLOGY LETTERS. 2001;120(1-3):259-268Ingelman-Sundberg M
- Published conference paper: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2001;281(5):1349-1355Westlind A; Malmebo S; Johansson I; Otter C; Andersson TB; Ingelman-Sundberg M; Oscarson M
- Published conference paper: CHEMICO-BIOLOGICAL INTERACTIONS. 2001;133(1-3):84-86Ingelman-Sundberg M
- Published conference paper: METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY. 2001;23(6):305Ingelman-Sundberg M
- Letter: PHARMACOGENETICS AND GENOMICS. 2000;10(1):91-93Ingelman-Sundberg M; Daly AK; Oscarson M; Nebert DW
- Published conference paper: FEBS LETTERS. 1999;460(2):309-314Neve EPA; Ingelman-Sundberg M
- Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 1999;20(8):342-349Ingelman-Sundberg M; Oscarson M; McLellan RA
- Review: FRONTIERS IN BIOSCIENCE - LANDMARK. 1999;4:d533-d540Albano E; French SW; Ingelman-Sundberg M
- Published conference paper: DRUG METABOLISM REVIEWS. 1999;31(2):467-487Nebert DW; Ingelman-Sundberg M; Daly AK
- Published conference paper: DRUG METABOLISM REVIEWS. 1999;31(2):449-459Ingelman-Sundberg M
- Published conference paper: TOXICOLOGY LETTERS. 1998;103:155-160Ingelman-Sundberg M
- Corrigendum: FEBS LETTERS. 1998;433(3):335Oligomerization properties of ERp29, an endoplasmic reticulum stress protein (vol 431, pg 322, 1998)Mkrtchian S; Baryshev M; Matvijenko O; Sharipo A; Sandalova T; Schneider G; Ingelman-Sundberg M
- Published conference paper: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 1998;22(3):740-742Albano E; French S; Ingelman-Sundberg M
- Published conference paper: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 1998;22(3):739-740Ingelman-Sundberg M; Lytton S; Albano E
- Published conference paper: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 1998;22(3):738-739French SW; Zhang-Gouillon ZQ; Ingelman-Sundberg M
- Conference publication: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 1998;22(3):742Badger TM; Korourian S; Hakkak R; Ronis MJJ; Shelnutt SR; Ingelman-Sundberg M; Waldron J
- Published conference paper: HEPATOLOGY. 1998;27(1):128-133Weltman MD; Farrell GC; Hall P; Ingelman-Sundberg M; Liddle C
- Conference publication: HEPATOLOGY. 1997;26(4):503French SW; ZhangGouillon ZQ; IngelmanSundberg M
- Conference publication: FASEB JOURNAL. 1997;11(9):A1376Hu Y; Oscarson M; Ingelman-Sundberg M
- Conference publication: FASEB JOURNAL. 1997;11(9):A1374Fang C; Lindros KO; Badger TM; Ronis MJJ; Ingelman-Sundberg M
- Conference publication: FASEB JOURNAL. 1997;11(9):A1061Mkrtchian S; Fang C; Hellman U; Ingelman-Sundberg M
- Conference publication: FASEB JOURNAL. 1997;11(9):A827Zhukov A; Ingelman-Sundberg M
- Conference publication: FASEB JOURNAL. 1997;11(9):A774Ingelman-Sundberg M
- Published conference paper: GASTROENTEROLOGY. 1997;113(1):265-276Clot P; Parola M; Bellomo G; Dianzani U; Carini R; Tabone M; Arico S; IngelmanSundberg M; Albano E
- Published conference paper: JOURNAL OF NUTRITION. 1997;127(5 Suppl):907S-911SFrench SW; Morimoto M; Reitz RC; Koop D; Klopfenstein B; Estes K; Clot P; IngelmanSundberg M; Albano E
- Review: ARCHIVES OF TOXICOLOGY. SUPPLEMENT. ARCHIV F�R TOXIKOLOGIE. SUPPLEMENT. 1997;19:3-13Ingelman-Sundberg M
- Published conference paper: ENVIRONMENTAL HEALTH PERSPECTIVES. 1996;104(Suppl 6):1183-1188Schrenk D; Orzechowski A; Schwarz LR; Snyder R; Burchell B; IngelmanSundberg M; Bock KW
- Conference publication: HEPATOLOGY. 1996;24(4):1261ZhangGouillon ZQ; Yuan QX; French B; Nagao Y; Miyamoto K; IngelmanSundberg M; French SW
- Review: PHARMACOGENETICS AND GENOMICS. 1996;6(3):193-201Daly AK; Brockmoller J; Broly F; Eichelbaum M; Evans WE; Gonzalez FJ; Huang JD; Idle JR; IngelmanSundberg M; Ishizaki T; JacqzAigrain E; Meyer UA; Nebert DW; Steen VM; Wolf CR; Zanger UM
- Review: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 1996;272:218-225Nedelcheva V; Persson I; IngelmanSundberg M
- Conference publication: HEPATOLOGY. 1995;22(4):481CLOT P; PAROLA M; BELLOMO G; TABONE M; ARICO S; INGELMANSUNDBERG M; ALBANO E
- Conference publication: FASEB JOURNAL. 1995;9(6):A1490ELIASSON E; ZHUKOV A; MCGEHEE R; KENNA JG; INGELMANSUNDBERG M
- Review: JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. 1995;37(1):25-36RANNUG A; ALEXANDRIE AK; PERSSON I; INGELMANSUNDBERG M
- Conference publication: HEPATOLOGY. 1994;20(4):A317CLOT P; INGELMANSUNDBERG M; BELLOMO G; TABONE M; ARICO S; ISRAEL Y; MONCADA C; ALBANO E
- Conference publication: FASEB JOURNAL. 1994;8(5):A806FRENCH SW; MORIMOTO M; DEGLIESPOSTI S; ZERN MA; HAGBJORK AL; INGELMANSUNDBERG M
- Book chapter: ASSESSMENT OF THE USE OF SINGLE CYTOCHROME P450 ENZYMES IN DRUG RESEARCH: ERNST SCHERING RESEARCH FOUNDATION WORKSHOP. 1994;p. 195-211Ingelman-Sundberg M; Zhukov A; Mkrtchian S; Eliasson E
- Book chapter: MEDICINAL IMPLICATIONS IN CYTOCHROME P-450 CATALYZED BIOTRANSFORMATIONS. 1993;p. 186-232Terelius Y; Lindros KO; Albano E; Ingelman-Sundberg M
- Conference publication: HEPATOLOGY. 1993;18(4):A123LINDROS KO; OINONEN T; BADGER T; RONIS M; HU Y; LONGO V; INGELMANSUNDBERG M
- Book chapter: FREE RADICALS: FROM BASIC SCIENCE TO MEDICINE: MOLECULAR AND CELL BIOLOGY UPDATES. 1993;p. 310-322Albano E; Clot P; Tabone M; Aricò S; Ingelman-Sundberg M
- Book chapter: FREE RADICALS: FROM BASIC SCIENCE TO MEDICINE: MOLECULAR AND CELL BIOLOGY UPDATES. 1993;p. 287-301Ingelman-Sundberg M
- Conference publication: HEPATOLOGY. 1992;16(4):A232HULTCRANTZ R; STAL P; JOHANSSON I; INGELMANSUNDBERG M
- Conference publication: HEPATOLOGY. 1992;16(2):534FRENCH SW; ALBANO E; HAGBJORK AL; INGELMANSUNDBERG M
- Conference publication: FASEB JOURNAL. 1991;5(6):A1614FRENCH SW; WONG K; MCKIBBON D; LUI L; INGELMANSUNDBERG M
- Conference publication: FASEB JOURNAL. 1991;5(5):A1451BADGER T; RONIS M; LUMPKIN C; INGELMANSUNDBERG M; SHAHARE M; MERCADO C; HUANG J; IRBY D; CROUCH J
- Conference publication: FASEB JOURNAL. 1991;5(5):A936RONIS M; HUANG J; INGELMANSUNDBERG M; BADGER TM
- Book chapter: ALCOHOLISM: NATO SCIENCE SERIES A:. 1991;p. 45-56Albano E; Ingelman-Sundberg M; Tomasi A; Poli G
- Conference publication: HEPATOLOGY. 1990;12(4):979FRENCH SW; TAKAHASHI H; JOHANSSON I; INGELMANSUNDBERG M
- Conference publication: ALCOHOL AND ALCOHOLISM. 1988;23(3):A64EKSTROM G; INGELMANSUNDBERG M
- Conference publication: ALCOHOL AND ALCOHOLISM. 1988;23(3):A64NORSTEN C; EKSTROM G; HANDLER JA; THURMAN RG; CRONHOLM T; INGELMANSUNDBERG M
- Conference publication: ALCOHOL AND ALCOHOLISM. 1988;23(3):A19INGELMANSUNDBERG M; NORSTEN C; EKSTROM G; HANDLER JA; THURMAN RG; CRONHOLM T
- Conference publication: ALCOHOL AND ALCOHOLISM. 1987;22(3):A15JOHANSSON I; INGELMANSUNDBERG M
- Conference publication: ALCOHOL AND ALCOHOLISM. 1987;22(3):A4INGELMANSUNDBERG M; EKSTROM G; TINDBERG N; JOHANSSON I
- Conference publication: ALCOHOL AND ALCOHOLISM. 1987;22(3):A14EKSTROM G; VONBAHR C; INGELMANSUNDBERG M
- Book chapter: CYTOCHROME P-450. 1986;p. 119-160Ingelman-Sundberg M
- Conference publication: ALCOHOL AND ALCOHOLISM. 1986;21(2):A20NORSTEN C; EKSTROM G; CRONHOLM T; INGELMANSUNDBERG M
- Book chapter: MICROSOMES, DRUG OXIDATIONS AND CHEMICAL CARCINOGENESIS. 1980;p. 513-516Ingelman–Sundberg M; Glaumann H; Johansson I
- Book chapter: MICROSOMES, DRUG OXIDATIONS AND CHEMICAL CARCINOGENESIS. 1980;p. 533-536Haaparanta T; Rydström J; Ingelman-Sundberg M
- Book chapter: MICROSOMES AND DRUG OXIDATIONS. 1977;p. xv-xxviiAchtert G; Agosin. M; Ahokas JT; Altmann H-J; Alvares AP; Arvela PI; Baars AJ; Von Bahr C; Batt A-M; Belvedere G; Bend JR; Bentley P; Berg A; Berggren M; Beyhl FE; Bock KW; Böttcher I; Boyd GS; Breckenridge AM; Brunner G; Budczies B; Burchell B; Busch U; Capdevila J; Carlström K; Charuel C; Cho AK; Conney AH; Coomes ML; Coon MJ; Cooper DY; Cox PJ; Cremer-Schlede E; Davies DS; Debey M-P; Denk H; Dickins M; Deutschmann G; Diehl H; Dietsch A; Down WH; Duppel W; Dus KM; Dybing E; Ebel D; Eben A; Elcombe CR; Ernster L; Estabrook RW; Fann WE; Fauran F; Fellenius E; Franklin M; Garbe A; Gelboin HV; Gielen J; Gillette JR; Glatt HR; Glazko AJ; Golan M; Gräfström R; Gram TE; Gunsalus IC; Gustafsson J-Å; Hänninen O; Haroz RK; Heinemeyer G; Herken H; Herzberg M; Herzberg W; Hesse S; Hildebrandt A; Hirata M; Hlavica P; Hoensch H; Hoffbauer RW; Högberg J; Holtzman JL; Ihlefeld H; Ingelman-Sundberg M; Jakobsson S; Jauch R; Jeffery E; Jerina D; Jernström B; Johannesen K; Joly J-G; Jonen HG; Jonsson J; Kärki N; Kahl GF; Kahl R; Kaminsky L; Kappas A; Kato R; Kaufmann R; Kewitz H; Kexel H; Kiese M; Kim S; Koch-Weser J; Kremers P; Kupfer D; Larsen JC; Lang M; Lech JJ; Lenk W; Levin W; Lieber CS; Lind C; Lindeke B; Lissner R; Lübke K; Maines MD; Mannering GJ; Marlowe CG; Marniemi J; Marselos M; Marsh J; Masters BSS; Mattern IE; Meyer UA; Mercier M; Mieyal JJ; Mitchell JR; Mohn G; Moldéus P; Moron M; Mosser J; Mull R; Muller-Eberhard U; Narasimhulu S; Nastainczyk W; Neal R; Nebert DW; Netter KJ; Noordhoek J; Novak RF; Oesch F; Okuda K; Omura T; Orrenius S; Orton TC; Paigen B; Paigen K; Parke DW; Pawlak A; Pederson TC; Pelkonen O; Peterson JA; Philpot RM; DePierre JW; Pitré D; Poensgen J; Powis G; Prough RA; Pyykkö K; Rafter JJ; Rahimtula A; Reed DJ; Remmer H; Rendic S; Roots I; Rosenthal O; Rubin A; Ruf H-H; Sato R; Schenkman JB; Scheulen M; Schleyer H; Schmassmann HU; Schmelz E; Schmid J; Schmidt H-L; Schmoldt A; Schoene K; Schoppler J; Schreiber E; Schulman M; Schulte-Hermann R; Schüppel R; Schuster I; Schwartzkopff T; Seidegard J; Sies H; Siest G; Sipal Z; Sligar SG; Snyder R; Sotaniemi EA; Spitzauer P; Staudinger H; Stier A; Stitzel R; Tanaka M; Temple DJ; Temple C; Tennekes HA; Terriere LC; Teschke R; Thenot J-P; Thor H; Thorgeirsson SS; Thurman RG; Traylor TG; Traylor PS; Trifilieff E; Tsibris JCM; Tunek A; Cuong PTC; Uehleke H; Ullrich V; Vadi H; Vähäkangas K; Vainio H; Vatsis KP; Vesell ES; Viljakainen E; Visser R; Volz M; Villeneuve J-P; Waddell WJ; Welch RM; Wende P; Wendt G; Werringloer J; Weymann J; Wiebel FJ; Wolf RC; Wolff T; Wollenberg P; Yang CS; Yang SK; Yasukochi Y; Yesair DW; Zehnder K; Ziegler DM; Zimmer A
- Book chapter: ABSTRACTS. 1977;p. 65Hrycay EG; Gustafsson J-Å; Ingelman-Sundberg M; Ernster L
- Book chapter: MICROSOMES AND DRUG OXIDATIONS. 1977;p. 377-384STUDIES ON A CYTOCHROME P-450-DEPENDENT HYDROXYLASE SYSTEM ACTIVE ON STEROIDS IN Bacillus megateriumBerg A; Carlström K; Ingelman-Sundberg M; Rafter J; Gustafsson J-Å
- Book chapter: MICROSOMES AND DRUG OXIDATIONS. 1977;p. 67-75Ingelman-Sundberg M
- Book chapter: PROCEEDINGS OF THE FOURTH INTERNATIONAL CONGRESS ON HORMONAL STEROIDS. 1976;p. 643-649GUSTAFSSON J-Å; INGELMAN-SUNDBERG M; STENBERG Å
- Conference publication: HOPPE-SEYLER'S ZEITSCHRIFT F�R PHYSIOLOGISCHE CHEMIE. 1976;357(8):1031INGELMANSUNDBERG M
- Conference publication: HOPPE-SEYLER'S ZEITSCHRIFT F�R PHYSIOLOGISCHE CHEMIE. 1976;357(8):1022-1023BERG A; CARLSTROM K; GUSTAFSSON JA; INGELMANSUNDBERG M
- Book chapter: RECENT ADVANCES IN STEROID BIOCHEMISTRY. 1975;p. 855-859GUSTAFSSON J-Å; GUSTAFSSON SA; INGELMAN-SUNDBERG M; POUSETTE Å; STENBERG Å; WRANGE Ö
- Visa fler
Forskningsbidrag
- Southern and Eastern Norway Regional Health Authority1 January 2022Biomarkers for tolerability of clozapine and risk of treatment discontinuation in patients with therapy-resistant schizophrenia<br/><br/>NOResearch stay abroadClozapine (Leponex) is the drug with the best effect in the treatment of schizophrenia. However, the risk of serious side effects limits its use. It is desirable to identify biomarkers that reflect the tolerability of the drug so that it can be used by more patients.Schizophrenia is the most serious of all mental disorders and normally requires lifelong drug treatment. Clozapine has the best clinical effect in the treatment of schizophrenia, but is also associated with an increased risk of agranulocytosis, a very serious side effect that places restrictions on its prescription. Current knowledge indicates that the mechanism behind clozapine-induced toxicity against granulocytes is linked to immunological reactions. To trigger an immunological reaction, a ‘substrate’ is required. Our hypothesis is that one or more breakdown products (metabolites) of clozapine represent ‘substrate(s)’ for such a reaction. <br/><br/>Clozapine has a complicated metabolism. Among these metabolites are so-called nitrenium ions, which are chemically very reactive substances. They bind to all types of proteins, including proteins in granulocytes. These metabolites are difficult to analyze in blood samples, precisely because they bind (covalently) to proteins in various cells. However, the body has a type of enzymes that can deactivate/capture the metabolites 'before they have time' to bind to proteins. These metabolites are quickly converted further into so-called cysteine metabolites, which are stable substances, and can thus be analyzed in blood samples. By analyzing the concentration of cysteine metabolites of clozapine in serum samples, one can thus get a picture of how much of the reactive nitrenium ions is formed.<br/><br/>The project has established a unique analysis method for measuring the level of cysteinyl metabolites in serum samples. The method is based on advanced chromatography coupled to a high-resolution mass spectrometer, which can analyze molecules with an exact mass. In total, the method can analyze the concentration/level of three cysteine metabolites of clozapine. Over the past year, the PhD fellow in the project has analyzed complete metabolite profiles of clozapine in 582 patients and compared levels of the different metabolites in relation to the genotype of "nuclear factor 1 B (NFIB)", which we have previously discovered regulates the activity of metabolizing enzymes. The results of the study show that patients who have the NFIB variant (approximately 10% of the population) have twice as high a concentration of the metabolites N-desmethylclozapine-cysteinyl, which probably reflects that these patients form more of the toxic metabolites and therefore have an increased risk of side effects and reduced tolerability of clozapine. However, these results must be verified in studies where there is better access to clinical data that reflect tolerability. We are already working on a study that will investigate both genotypes and levels of toxic metabolites in patients who terminate clozapine treatment (the hypothesis is increased prevalence of the NFIB variant and/or levels of cysteinyl metabolites in patients who terminate treatment). It is also planned to study the extent to which combination treatment with fluvoxamine, an antidepressant drug, affects the formation of cysteinyl metabolites. The hypothesis in the latter study is that fluvoxamine reduces the formation of toxic metabolites, since combination treatment with fluvoxamine is associated with better tolerability of clozapine. <br/><br/>A manuscript describing the formation of clozapine metabolites in relation to NFIB genotype has been submitted for publication, and is currently "under review" in the journal Drug Metabolism and Disposition. This article will be published in 2025. The ambition is also to publish one or both of the other substudies described above during 2025.<br/>
- Southern and Eastern Norway Regional Health Authority1 January 2020 - 31 December 2023
- A novel regimen for treatment of colon cancer using CYP2W1 as a tumor selective targetNovo Nordisk Foundation1 January 2019 - 31 December 2021
- Swedish Research Council1 December 2018 - 31 December 2023
- CYP2W1 as a prognostic marker and target for pharmacological treatment of colon and liver cancerSwedish Cancer Society1 January 2018Each year, approximately 4,100 people receive colon cancer in Sweden and 500 people have liver cancer. If the cancer spreads after surgical treatment, chemotherapy is needed. We have found an enzyme (CYP2W1) that is specifically only found in colon cancer cells and liver cancer cells as well as in some other tumor forms but not in normal tissue. We find this enzyme in higher amounts in liver metastases is in primary colon tumor. We have also developed chemical compounds which by reacting by the enzyme form reactive products that kill the tumor cells. If we treat mice that have a human colon tumor containing CYP2W1 with these compounds, the tumor cannot grow. The project aims to develop even better compounds that are substrates for CYP2W1, to investigate in which other tumor forms the enzyme exists where one can imagine a similar treatment. We will investigate whether CYP2W1 mRNA and peptides from CYP2W1 and deethylated DNA fragments from CYP2W1 genes can serve as new markers for the presence of colon cancer and other human tumors. Furthermore, we want to determine the enzyme structure to produce even better cancer drugs, identify the electron donors to the enzyme needed and see how the enzyme is regulated in tumor cells to find other drugs that upregulate the expression of the enzyme in the tumors. We hope through the project to be able to identify a completely new specific biomarker for colon cancer and liver cancer and to be able to start clinical trials with the substances we identified for a principally new way of treating colon cancer and other cancer.
- Southern and Eastern Norway Regional Health Authority1 January 2018 - 31 December 2022
- European Research Council1 September 2017 - 30 June 2023
- VINNOVA1 March 2017 - 28 February 2019
- CYP2W1 as a prognostic marker and target for pharmacological treatment of colon and liver cancerSwedish Cancer Society1 January 2017Each year, approximately 4,100 people receive colon cancer in Sweden and 500 people have liver cancer. If the cancer spreads after surgical treatment, chemotherapy is needed. We have found an enzyme (CYP2W1) that is specifically only found in colon cancer cells and liver cancer cells as well as in some other tumor forms but not in normal tissue. We find this enzyme in higher amounts in liver metastases is in primary colon tumor. We have also developed chemical compounds which by reacting by the enzyme form reactive products that kill the tumor cells. If we treat mice that have a human colon tumor containing CYP2W1 with these compounds, the tumor cannot grow. The project aims to develop even better compounds that are substrates for CYP2W1, to investigate in which other tumor forms the enzyme exists where one can imagine a similar treatment. We will investigate whether CYP2W1 mRNA and peptides from CYP2W1 and deethylated DNA fragments from CYP2W1 genes can serve as new markers for the presence of colon cancer and other human tumors. Furthermore, we want to determine the enzyme structure to produce even better cancer drugs, identify the electron donors to the enzyme needed and see how the enzyme is regulated in tumor cells to find other drugs that upregulate the expression of the enzyme in the tumors. We hope through the project to be able to identify a completely new specific biomarker for colon cancer and liver cancer and to be able to start clinical trials with the substances we identified for a principally new way of treating colon cancer and other cancer.
- Swedish Research Council1 January 2017 - 31 December 2019
- New methods of treating colon cancer and other cancers by using CYP2W1 as a target for drug activationSwedish Cancer Society1 January 2016Each year, approximately 4,100 people receive colon cancer in Sweden. If the cancer spreads after surgical treatment, chemotherapy is needed. We have found an enzyme (CYP2W1) that is specifically only found in colon cancer cells and in some other tumor forms but not in normal tissue. We find this enzyme in higher amounts in liver metastases. We have also developed chemical compounds which by reacting by the enzyme form reactive products that kill the tumor cells. If we treat mice that have a human colon tumor containing CYP2W1 with these compounds, the tumor cannot grow. The project aims to develop even better compounds that are substrates for CYP2W1, to investigate in which other tumor forms the enzyme exists where one can envisage a similar treatment, to use mRNA and peptides from CYP2W1 gene expression as a new marker for the presence of colon cancer and other tumors in humans. Furthermore, we want to determine the enzyme structure to produce even better cancer drugs, identify the electron donors to the enzyme needed and see how the enzyme is regulated in tumor cells to find other drugs that upregulate the expression of the enzyme in the tumors. We hope through the project to be able to identify a completely new specific biomarker for colon cancer and some other tumor forms and to be able to start clinical trials with the substances we identified for a principally new way of treating colon cancer and other cancer.
- Swedish Research Council1 January 2016 - 31 December 2019
- Swedish Research Council1 January 2016 - 31 December 2016
- New methods of treating colon cancer and other cancers by using CYP2W1 as a target for drug activationSwedish Cancer Society1 January 2015Each year, approximately 4,100 people receive colon cancer in Sweden. If the cancer spreads after surgical treatment, chemotherapy is needed. We have found an enzyme (CYP2W1) that is specifically only found in colon cancer cells and in some other tumor forms but not in normal tissue. We find this enzyme in higher amounts in liver metastases. We have also developed chemical compounds which by reacting by the enzyme form reactive products that kill the tumor cells. If we treat mice that have a human colon tumor containing CYP2W1 with these compounds, the tumor cannot grow. The project aims to develop even better compounds that are substrates for CYP2W1, to investigate in which other tumor forms the enzyme exists where one can envisage a similar treatment, to use mRNA and peptides from CYP2W1 gene expression as a new marker for the presence of colon cancer and other tumors in humans. Furthermore, we want to determine the enzyme structure to produce even better cancer drugs, identify the electron donors to the enzyme needed and see how the enzyme is regulated in tumor cells to find other drugs that upregulate the expression of the enzyme in the tumors. We hope through the project to be able to identify a completely new specific biomarker for colon cancer and some other tumor forms and to be able to start clinical trials with the substances we identified for a principally new way of treating colon cancer and other cancer.
- New methods of treating colon cancer and other cancers by using CYP2W1 as a target for drug activationSwedish Cancer Society1 January 2014Each year, approximately 4,100 people receive colon cancer in Sweden. If the cancer spreads after surgical treatment, chemotherapy is needed. We have found an enzyme (CYP2W1) that is specifically only found in colon cancer cells and in some other tumor forms but not in normal tissue. We find this enzyme in higher amounts in liver metastases. We have also developed chemical compounds which by reacting by the enzyme form reactive products that kill the tumor cells. If we treat mice that have a human colon tumor containing CYP2W1 with these compounds, the tumor cannot grow. The project aims to develop even better compounds that are substrates for CYP2W1, to investigate in which other tumor forms the enzyme exists where one can envisage a similar treatment, to use mRNA and peptides from CYP2W1 gene expression as a new marker for the presence of colon cancer and other tumors in humans. Furthermore, we want to determine the enzyme structure to produce even better cancer drugs, identify the electron donors to the enzyme needed and see how the enzyme is regulated in tumor cells to find other drugs that upregulate the expression of the enzyme in the tumors. We hope through the project to be able to identify a completely new specific biomarker for colon cancer and some other tumor forms and to be able to start clinical trials with the substances we identified for a principally new way of treating colon cancer and other cancer.
- ERA-NET NEURON Mental Disorders RDmaria aDBSSwedish Research Council1 January 2014 - 31 December 2016
- Swedish Research Council1 January 2011 - 31 December 2015
- Swedish Research Council1 January 2009 - 31 December 2011
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning20 November 2008 - 31 December 2008
- Visa fler
Anställningar
- Professor, Senior, Fysiologi och farmakologi, Karolinska Institutet, 2025-2025
- Professor, Fysiologi och farmakologi, Karolinska Institutet, 2020-2024
Examina och utbildning
- Docent, Medicinsk o fysiologisk kemi, Karolinska Institutet, 1977